hg_167501.1

Basic information about the TSS

---

TSS ID: hg_167501.1 Species: human Chr: chr17		Start: 63842886 End: 63842912 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000448276.6 uc010deb.2 BC142963 Distance: -28 GeneID: 6603 HGNC/MGI_ID: HGNC:11107 UniProt_ID: Q92925

Gene_name: "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Gene_symbol: SMARCD2 Gene_synonyms: BAF60B CRACD2 PRO2451 Rsc6p Gene_source: HGNC:11107

TATA-Box annotation

---

Distance to TSS:	92
Nearest PromoterID:	NM_001098426
Entrez ID:	6603
Nearest Unigene:	Hs.250581
Nearest Refseq:	NM_003077
Nearest Ensembl:	ENSG00000108604
Gene Name:	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"
Gene Alias:	BAF60B
Gene Description:	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"
Gene Type:	protein-coding
CpG%:	0.1
GC%:	0.671642
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SMARCD2 p2@SMARCD2 p3@SMARCD2 p4@SMARCD2 p5@SMARCD2 p6@SMARCD2 p9@SMARCD2 p10@SMARCD2
Sample		p1@SMARCD2	p2@SMARCD2	p3@SMARCD2	p4@SMARCD2	p5@SMARCD2	p6@SMARCD2	p9@SMARCD2	p10@SMARCD2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	27.27	10.32	6.04	0.58	1.17	0.97	0.00	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.74	8.90	6.88	0.20	1.21	0.81	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.39	8.87	5.98	1.35	1.74	0.96	0.19	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.45	6.45	6.03	1.04	1.25	1.66	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.67	11.25	8.55	1.35	0.22	0.67	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	19.38	10.47	7.36	0.19	1.16	0.39	0.19	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.91	12.42	11.98	1.53	1.31	1.96	0.00	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	34.88	11.38	7.51	0.97	0.48	0.97	0.00	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.17	9.83	8.12	1.50	1.28	1.07	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	29.56	11.59	5.80	0.00	2.32	2.32	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	27.49	11.72	7.28	0.40	1.62	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	8.94	6.50	0.81	0.00	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.34	6.61	1.61	0.64	1.29	0.32	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.64	5.26	1.50	0.90	1.35	0.45	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.10	4.17	2.42	0.00	0.88	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	5.28	0.25	0.75	0.75	0.00	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.94	3.93	1.53	0.66	0.87	0.44	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.08	5.06	0.42	1.27	0.00	0.00	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	5.86	0.53	0.00	1.07	0.00	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.05	5.57	1.96	0.45	0.90	0.15	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	17.64	6.82	3.74	0.94	0.53	0.27	0.27	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.74	7.25	2.07	0.52	0.52	0.17	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.31	4.65	2.33	0.13	0.90	0.39	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.32	5.10	3.15	0.24	0.73	0.24	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	5.93	2.58	1.03	0.00	0.00	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.61	5.38	1.58	0.95	0.32	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	3.85	1.10	1.65	0.55	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.97	7.31	2.36	0.71	0.47	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.15	5.01	1.62	1.45	1.13	0.16	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.66	5.43	1.81	0.36	0.54	0.18	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.93	6.49	3.14	0.84	0.42	0.21	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.04	6.84	1.76	0.20	0.39	0.39	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.76	5.06	2.11	0.00	0.42	0.00	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.93	3.30	0.49	1.15	0.16	0.16	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.65	3.55	2.99	0.37	0.00	0.19	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.14	3.83	2.49	0.57	1.15	0.77	0.38	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.94	2.66	1.43	0.61	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.90	5.44	1.81	0.60	0.00	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	7.02	2.43	0.81	0.81	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.52	4.08	1.44	0.24	0.00	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	3.76	1.88	0.47	0.94	0.00	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.52	4.25	0.44	0.73	0.44	0.15	0.15	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9.91	6.12	0.84	0.00	0.21	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.62	4.72	1.57	0.70	0.52	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.65	4.82	1.61	0.00	0.60	0.60	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.14	5.35	3.26	0.00	0.23	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.36	3.60	1.92	0.24	0.48	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.90	5.96	0.30	0.89	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.86	3.83	1.91	0.96	0.48	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.29	5.66	1.42	0.81	0.40	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.61	5.94	1.23	1.64	0.82	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.78	8.89	1.33	0.67	0.44	0.67	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	10.29	7.81	1.77	0.71	0.35	0.35	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.95	6.30	0.99	0.99	0.66	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1.68	2.52	0.00	0.84	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	5.05	0.46	1.38	1.38	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.48	5.83	0.32	0.97	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.99	6.42	1.93	0.32	0.00	0.00	0.32	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	5.34	0.00	1.26	0.31	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.94	4.94	0.00	0.71	1.41	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.93	4.49	2.24	0.56	0.56	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.98	1.59	0.00	0.80	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	3.74	0.34	0.34	0.68	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	5.52	1.62	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	4.97	1.06	0.00	0.71	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	7.90	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	5.85	0.98	1.46	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	7.44	0.50	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.16	7.04	0.94	0.94	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.30	5.30	0.33	0.33	0.99	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.81	7.42	1.24	0.62	0.93	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	7.03	1.83	0.31	1.22	0.00	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	13.15	6.97	2.69	2.53	1.58	0.63	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	17.17	8.98	3.53	1.12	1.76	0.32	0.00	1.28
Adipocyte - omental, donor1	11473-119C6	8.78	4.71	2.54	1.65	0.76	0.51	0.64	0.13
Adipocyte - omental, donor2	11474-119C7	8.97	4.48	2.24	0.75	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	8.71	1.67	1.34	1.67	1.34	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.29	3.19	1.28	0.64	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	4.40	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	7.23	2.26	1.81	2.26	1.35	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	21.03	13.03	2.43	2.09	2.61	0.52	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	13.69	6.06	1.96	2.15	0.39	0.00	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	8.49	4.89	1.54	1.03	1.29	0.26	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	9.20	8.36	0.84	0.84	0.84	0.56	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	11.17	5.88	2.35	2.35	0.59	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	9.73	6.19	1.13	1.21	0.97	0.00	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	5.49	6.46	0.97	1.94	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	2.67	7.46	2.13	2.13	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	2.78	3.90	0.56	0.56	0.56	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	11.64	5.41	1.66	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	6.78	3.52	0.75	0.50	1.00	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	4.91	0.65	1.64	0.98	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.39	2.74	0.91	0.30	1.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	15.47	12.82	1.99	1.10	0.88	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	26.54	25.10	1.43	1.08	2.51	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	14.38	2.40	2.40	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.47	19.61	1.08	2.16	1.08	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	15.06	5.02	5.02	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	19.93	24.45	2.05	2.05	1.03	1.23	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	26.09	4.35	1.83	0.92	1.95	2.86	0.57	0.11
Anulus Pulposus Cell, donor2	11463-119B5	16.41	3.92	0.49	0.98	2.20	1.96	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	4.49	0.00	0.45	1.35	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	3.91	5.21	0.00	0.43	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	4.28	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	5.08	5.68	0.60	1.49	1.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	0.00	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	3.30	1.32	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	5.20	4.22	0.65	0.65	0.32	0.97	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.34	1.94	0.49	0.49	0.49	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.38	3.56	0.00	0.00	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	3.39	2.26	0.75	0.75	0.38	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	2.51	1.25	0.00	1.25	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.61	2.80	0.82	1.65	0.33	0.33	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	4.09	0.00	1.36	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.37	1.36	0.15	0.45	0.45	0.15	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	4.29	0.54	0.54	0.54	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.86	4.91	0.94	0.38	0.19	0.38	0.00	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.61	3.21	0.80	0.53	0.00	1.07	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	0.98	0.00	0.98	0.98	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.97	3.15	0.83	0.17	0.17	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	5.66	2.23	0.86	1.03	0.51	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.43	4.37	0.00	0.00	0.49	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.17	1.14	0.38	1.14	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	1.21	2.42	2.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	2.85	0.00	0.57	1.71	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.20	3.85	0.64	1.28	0.86	0.86	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.94	3.10	0.26	0.52	0.52	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	3.75	5.63	0.47	0.94	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	2.25	0.32	0.64	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.14	1.43	0.00	0.71	0.71	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.09	1.17	1.17	1.17	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.23	4.22	0.00	0.60	0.60	0.30	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	2.38	0.00	1.19	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	4.07	0.51	0.00	0.00	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.33	4.08	0.25	1.02	1.02	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	0.64	1.27	0.64	0.64	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	4.32	0.43	0.00	0.00	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	3.18	0.64	0.21	0.42	1.06	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.48	3.19	0.58	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	4.72	0.00	0.00	0.00	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	2.37	0.51	0.34	0.17	0.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	2.32	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.29	3.22	0.86	0.64	0.21	0.00	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	2.41	4.21	1.20	1.20	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	1.46	0.00	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	3.45	3.68	0.23	1.15	0.46	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	7.65	0.00	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.29	0.76	0.76	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.19	3.92	0.41	0.41	0.62	0.83	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.59	3.06	0.61	1.84	0.92	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.65	2.87	0.00	2.39	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	4.43	3.99	0.67	0.67	0.67	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.75	3.32	1.11	1.66	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.36	2.65	0.79	0.26	0.53	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.45	2.91	1.45	1.09	1.09	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	19.90	7.74	1.72	1.23	0.49	0.37	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	16.60	5.82	1.20	1.20	0.68	0.17	0.51	0.51
Astrocyte - cerebellum, donor3	11661-122F5	13.63	4.82	1.68	0.42	0.21	0.42	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	5.58	2.44	1.39	1.05	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	9.54	4.85	0.32	0.49	0.32	0.16	0.32	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	7.61	4.47	1.04	0.60	0.60	0.15	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.85	36.01	0.80	3.10	0.69	0.00	0.23	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	6.89	29.82	0.50	3.51	0.63	0.13	0.00	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.46	28.11	0.80	3.41	0.91	0.00	0.34	0.57
Basophils, donor1	12241-129G9	8.37	22.49	0.00	0.00	0.52	0.26	0.00	0.00
Basophils, donor2	12242-129H1	6.86	21.65	0.00	0.36	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	13.67	11.02	0.73	0.44	1.03	0.29	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	31.05	6.47	2.59	0.43	1.51	0.86	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	28.35	10.06	7.31	2.29	2.74	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	5.65	1.88	0.63	4.39	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	21.21	7.69	2.50	1.46	1.46	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	16.81	2.76	2.07	0.69	1.38	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	21.95	3.78	2.34	0.00	0.54	0.72	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.83	34.52	2.89	2.47	0.93	0.93	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	46.58	15.84	8.62	1.63	3.03	1.40	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	18.55	26.54	0.96	3.20	0.96	0.32	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	9.02	12.96	0.00	1.13	1.13	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	8.54	15.59	0.37	0.00	0.74	0.00	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	13.61	14.71	0.22	0.22	0.66	0.00	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.77	13.59	0.00	1.98	1.70	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	9.86	0.00	1.90	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.20	11.51	0.00	1.31	2.30	0.00	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	13.30	16.77	0.43	3.90	2.31	0.00	0.87	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	8.75	0.00	2.11	1.51	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	10.66	12.79	0.00	2.13	1.90	0.00	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.36	12.22	0.17	1.84	1.51	0.00	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.90	6.07	0.00	1.66	0.55	0.28	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.95	11.16	0.00	0.99	0.50	0.50	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.66	9.79	0.59	0.59	0.78	0.00	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.90	5.70	0.18	0.18	0.89	0.00	0.89	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.23	6.53	0.00	0.44	0.44	0.00	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.32	7.96	0.00	0.70	0.70	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.78	8.45	1.06	0.53	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	12.20	0.00	0.00	2.22	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.18	12.94	0.30	1.64	2.08	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.19	10.38	0.20	1.00	1.20	0.00	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.16	8.54	0.00	1.87	0.42	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.55	12.58	0.23	0.92	1.37	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.07	6.11	0.23	0.68	1.13	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	12.22	0.44	0.44	0.44	0.00	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.61	12.64	0.00	1.08	1.34	0.00	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	10.99	8.37	0.00	0.17	0.87	0.17	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.15	9.26	0.42	0.42	1.68	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.41	6.25	0.00	0.55	0.18	0.00	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	7.05	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	9.65	0.44	0.44	1.32	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	8.54	0.35	0.52	0.35	0.00	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	9.66	9.66	0.74	0.74	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.92	9.92	0.00	0.86	1.72	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	9.01	1.23	0.82	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.49	5.56	0.00	0.23	0.46	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.10	5.80	0.46	0.23	0.93	0.00	0.70	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.10	19.40	0.00	0.65	1.09	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.24	19.40	0.23	1.39	1.85	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	7.36	13.86	0.00	0.65	1.73	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	18.22	19.93	0.47	2.65	4.05	0.00	1.09	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	22.70	13.27	0.52	2.97	3.49	0.17	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	16.50	16.95	0.22	2.23	2.90	0.00	1.78	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	3.83	24.75	0.00	3.06	0.51	0.00	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	7.90	24.81	0.00	3.29	2.20	0.44	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	5.26	22.74	0.21	0.63	0.42	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	46.74	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	51.53	0.00	3.39	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	51.78	0.00	3.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.26	57.04	0.00	2.67	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.68	61.65	0.00	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.11	44.22	0.00	2.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	41.57	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	52.73	0.00	2.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	63.29	0.82	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	42.80	0.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	3.53	57.55	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.46	23.44	1.62	2.02	0.40	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.99	23.17	2.40	2.40	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	16.06	1.00	1.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	3.37	24.72	1.12	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.79	31.19	2.25	4.51	0.75	1.13	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.68	22.10	3.61	2.25	2.71	0.90	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	3.93	46.06	0.00	0.00	0.36	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	6.74	53.28	0.00	1.22	0.61	0.61	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	4.88	46.66	0.91	2.13	0.00	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.36	49.77	0.26	3.32	0.26	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.27	51.66	0.90	5.17	0.22	0.45	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.75	48.29	2.01	5.75	0.00	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.79	58.79	0.47	3.79	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	61.80	0.70	1.40	0.00	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	72.52	0.00	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.89	37.00	0.58	7.37	0.14	0.00	0.00	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.25	54.23	0.51	4.91	0.17	0.17	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.87	38.37	0.48	2.26	0.32	0.16	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.24	52.90	0.00	2.24	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.19	49.61	0.00	3.14	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	2.20	52.80	0.00	3.52	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	45.54	0.00	2.11	0.00	0.42	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.91	37.81	0.00	4.78	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1.67	43.44	0.00	2.67	0.67	0.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	44.05	0.00	1.36	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	6.43	47.70	0.54	1.61	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	55.59	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.08	51.18	0.37	6.30	0.37	0.19	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.33	40.72	0.43	4.55	0.00	0.00	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.57	44.97	0.21	3.99	0.21	0.21	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.06	42.47	0.51	2.02	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	5.20	52.42	0.00	1.30	0.00	0.00	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	4.79	48.38	0.00	2.61	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	3.96	52.46	0.49	4.45	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1.85	52.62	0.00	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	53.04	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	3.32	54.83	0.28	3.60	0.55	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	5.40	56.19	0.74	1.47	0.25	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	4.62	63.14	1.54	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.80	53.36	0.36	2.15	0.36	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	65.09	0.00	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	3.27	44.85	0.33	0.33	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	4.13	58.19	0.00	2.25	0.38	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	6.31	54.79	0.50	1.26	0.00	0.25	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.73	11.47	3.67	4.36	0.92	0.46	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.83	15.10	3.59	2.40	0.48	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.02	13.68	1.64	3.01	0.82	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	11.41	1.50	0.90	0.60	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.52	10.56	3.36	3.12	1.20	0.24	0.00	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	9.55	2.05	3.18	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.08	9.34	3.26	1.74	0.00	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.53	12.11	2.63	2.90	0.26	0.53	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.69	9.38	2.35	1.88	1.41	0.00	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.75	13.58	2.42	1.81	0.91	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	6.39	3.49	1.45	0.58	0.00	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	8.79	4.53	2.13	0.27	0.00	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	5.25	8.32	2.63	1.75	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.19	7.74	1.82	1.82	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	0.75	2.24	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.68	14.77	2.16	3.24	1.08	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.45	12.37	4.03	2.88	0.58	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.54	12.02	3.30	2.36	0.94	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	9.51	3.80	3.49	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.84	9.53	5.54	2.77	0.92	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	11.54	3.85	2.24	0.64	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	6.50	3.44	1.53	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	4.34	10.25	4.34	3.15	1.18	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	6.05	1.51	1.51	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	6.42	8.03	0.80	1.61	0.80	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	6.99	0.70	0.70	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	5.01	7.01	3.01	0.00	0.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	16.45	12.79	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.85	2.96	4.45	0.49	0.49	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	9.26	6.42	2.10	0.74	0.84	0.53	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	14.56	2.77	1.39	1.39	0.69	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.31	2.84	1.42	0.71	0.71	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	15.25	4.21	2.73	0.57	1.59	0.80	0.23	0.57
Chondrocyte - re diff, donor2	11339-117F7	7.16	0.90	0.90	0.00	0.90	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	14.15	3.64	2.43	0.81	0.00	1.21	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	14.46	4.93	2.87	0.69	1.15	0.23	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	3.42	1.50	0.86	0.21	0.21	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	16.90	3.63	3.10	0.53	0.44	0.18	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.97	10.73	2.29	1.19	1.74	0.46	0.46	0.37
Corneal Epithelial Cells, donor1	11526-119I5	40.84	11.86	2.20	1.54	2.63	1.10	0.66	0.44
Corneal Epithelial Cells, donor2	11606-120I4	43.23	13.65	3.41	2.28	6.83	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	43.20	7.92	4.09	0.51	2.30	0.51	0.26	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.96	3.47	8.58	3.30	2.81	0.17	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.39	4.73	5.68	1.89	3.47	0.32	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	0.00	6.90	3.45	6.90	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.93	6.80	7.99	1.73	3.02	0.11	0.43	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.62	29.38	1.02	3.07	0.68	0.00	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.75	31.99	0.00	2.61	1.31	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.19	28.07	0.00	3.87	0.00	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	6.84	4.00	1.67	1.67	1.17	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	4.69	0.59	0.59	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.99	3.11	2.26	0.57	1.41	0.57	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.04	1.97	0.79	0.79	0.39	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	14.54	4.07	1.16	0.00	1.16	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	13.41	4.94	1.18	1.41	0.71	0.24	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	11.40	2.45	1.58	0.88	0.70	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.64	4.43	1.11	1.33	1.11	0.22	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.21	2.74	0.61	0.30	1.22	0.30	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.99	2.54	1.13	1.69	0.28	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	8.62	3.27	0.30	0.89	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	1.56	0.52	1.04	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.51	3.40	0.28	0.71	0.43	0.14	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	14.00	4.80	0.00	1.60	0.80	0.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	12.05	4.19	1.05	1.57	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	15.78	5.96	1.99	2.36	1.49	0.62	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.68	3.48	1.52	0.43	0.87	0.65	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.58	6.35	1.47	0.98	2.08	0.37	0.61	0.12
Endothelial Cells - Vein, donor1	11267-116G7	17.06	1.14	4.55	1.14	2.28	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	6.99	0.70	0.70	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.31	4.55	2.67	1.57	2.20	0.31	0.63	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	67.66	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	49.94	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	22.48	6.35	4.15	0.00	0.98	1.22	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	4.16	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.69	2.46	1.64	0.82	0.00	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.39	3.28	1.20	0.88	0.33	0.44	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.89	4.23	1.95	1.08	0.87	0.54	0.43	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.16	4.12	1.70	0.97	0.49	0.36	0.12	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.00	12.15	0.41	1.36	0.68	0.68	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7.17	5.17	2.11	1.05	0.53	0.42	0.11	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.96	5.80	1.84	1.58	0.79	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.96	5.65	3.65	0.66	0.66	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	12.70	4.08	2.27	0.00	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.82	6.06	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.73	5.68	1.26	0.32	0.47	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	16.37	6.97	3.33	1.82	1.21	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.18	6.35	1.40	0.25	0.76	0.13	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	11.07	6.06	1.06	1.06	0.61	0.30	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.84	5.76	1.34	1.61	1.88	0.94	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	3.02	3.02	0.43	1.29	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	10.25	2.93	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	25.60	4.61	3.69	0.69	0.92	1.61	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	56.14	11.19	11.70	2.20	2.88	3.39	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	19.72	6.10	3.99	1.64	2.58	0.94	0.23	0.70
Fibroblast - Dermal, donor2	11346-117G5	25.94	5.66	0.94	1.89	1.42	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	27.08	4.47	9.07	1.33	2.06	0.85	0.60	0.60
Fibroblast - Dermal, donor4	11450-119A1	16.84	6.67	1.70	1.13	1.70	0.57	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	16.92	6.28	3.31	0.87	0.87	0.52	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	17.54	6.98	3.25	1.30	0.49	0.81	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	22.70	6.25	1.87	1.46	1.67	0.21	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.12	5.24	1.83	1.31	0.26	0.26	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	15.42	7.12	1.71	1.58	1.32	0.53	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	36.45	7.73	5.51	1.74	3.09	0.87	0.48	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	4.16	2.08	1.04	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.34	2.64	1.23	1.06	0.53	0.00	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.00	6.86	1.71	2.34	0.94	0.62	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.03	3.65	1.22	1.76	1.35	0.00	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	6.00	0.35	1.06	0.71	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	6.14	3.95	1.75	0.73	0.44	0.15	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6.41	4.91	1.09	0.95	1.64	0.27	0.41	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	4.83	4.06	0.77	0.44	1.10	0.33	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.74	2.93	0.59	0.88	2.35	0.00	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	28.55	2.72	1.36	2.72	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	26.86	1.49	2.98	2.98	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	25.54	7.39	5.70	2.32	0.42	0.63	0.21	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	4.17	5.00	0.83	3.33	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	4.20	8.39	2.80	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.35	6.44	3.92	1.96	0.28	1.40	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	27.20	7.31	6.09	1.62	4.06	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	16.10	6.60	2.33	1.75	0.78	0.78	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.99	9.86	2.12	1.82	1.82	0.46	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.83	3.67	2.75	0.92	0.31	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	4.96	3.43	0.38	0.38	0.76	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.02	3.24	1.89	1.62	0.54	0.00	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5.45	2.90	0.93	0.81	1.04	0.12	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.74	5.31	1.33	0.77	0.88	0.55	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.83	11.58	1.42	2.03	0.81	0.61	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	11.36	2.67	2.00	2.00	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	5.14	6.72	0.79	1.58	1.19	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	8.93	9.33	0.79	1.19	0.60	0.60	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.59	3.20	1.07	1.24	0.89	0.18	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.88	5.12	1.38	1.18	1.18	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.22	9.03	1.20	1.20	0.60	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.63	5.61	1.08	0.54	1.51	0.65	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.65	9.62	0.00	2.28	2.53	0.76	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	13.62	4.10	1.15	1.15	0.66	0.16	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	11.23	10.03	0.20	1.80	1.00	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	9.14	5.63	0.90	1.21	1.11	0.40	0.40	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.41	11.79	1.21	1.21	0.91	0.91	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.01	5.22	1.82	1.33	1.16	0.25	0.75	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.29	6.84	1.03	1.03	0.85	1.20	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.90	11.17	0.33	1.31	0.99	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.08	5.75	1.07	0.96	0.85	0.11	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	12.31	6.07	2.19	0.84	1.35	0.67	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.10	3.45	0.78	0.47	0.31	0.47	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	6.10	3.49	1.74	0.87	0.00	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	4.68	8.32	0.52	2.08	1.04	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.20	7.03	0.78	1.30	0.52	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.50	5.88	0.51	1.02	0.51	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	32.92	9.19	6.12	0.00	0.77	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	6.38	6.38	0.64	1.28	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	28.81	12.84	2.85	0.29	2.85	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	30.61	3.03	4.96	0.28	0.55	0.00	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.41	1.60	2.74	0.46	0.91	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.30	10.30	5.55	0.99	1.59	0.40	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	39.39	5.29	3.70	0.79	0.53	0.00	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.87	1.63	2.61	0.65	0.33	0.00	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.02	9.73	2.21	0.88	1.33	0.00	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.33	9.33	3.82	1.41	2.12	0.71	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.63	7.02	2.71	0.74	2.59	0.74	0.62	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	19.88	7.79	4.57	1.07	1.07	0.81	0.54	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	20.94	7.56	1.73	1.36	1.24	0.12	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.53	7.06	2.08	1.38	0.55	0.14	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	14.64	4.07	1.22	0.61	0.81	0.20	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.71	5.93	1.60	0.46	0.91	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	22.30	6.23	1.74	0.62	2.49	0.62	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.29	6.34	1.53	1.09	0.87	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.07	4.14	2.95	1.48	1.48	0.59	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.73	6.84	1.27	1.11	2.23	0.32	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.09	4.92	1.56	0.67	0.89	0.67	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	16.13	6.25	3.23	1.41	0.40	0.20	0.20	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.12	4.24	1.02	1.36	0.68	0.51	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.43	7.80	2.66	0.89	0.44	0.44	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.63	8.12	2.19	0.73	1.04	0.52	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.42	6.32	3.07	0.51	1.54	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.13	4.98	1.88	0.77	1.77	0.33	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.81	6.16	2.00	0.67	1.33	0.50	0.25	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.86	5.31	1.43	0.82	0.82	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.65	4.75	2.89	0.83	0.41	0.41	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	22.14	6.23	1.96	1.61	0.81	0.58	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.84	6.17	2.84	0.33	0.67	0.83	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.78	6.61	2.87	0.44	1.54	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.69	7.38	1.84	0.25	1.60	0.25	0.25	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.94	6.48	2.43	1.30	0.32	0.16	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	11.55	5.77	3.85	0.32	0.64	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	13.36	5.21	1.99	0.85	1.80	0.19	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.76	5.85	1.90	0.47	0.95	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.82	6.69	0.61	0.00	0.61	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.96	5.33	1.05	1.36	1.57	0.10	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.34	6.59	3.73	0.44	0.44	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.82	7.29	1.12	0.56	0.84	0.28	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.80	5.09	0.83	0.65	1.39	0.09	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.24	4.55	1.87	0.80	1.34	1.87	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.49	5.81	2.14	1.07	1.53	0.00	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.34	6.35	1.55	0.65	1.42	0.13	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.99	6.51	4.88	0.27	0.54	1.36	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	9.59	8.48	2.03	0.74	2.21	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	11.18	4.17	1.54	0.44	1.54	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	13.88	5.95	1.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.42	5.80	3.03	0.92	0.66	0.40	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.12	5.65	2.22	1.21	0.40	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	16.52	4.57	2.80	0.25	0.76	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	32.45	12.94	2.39	0.60	2.39	0.60	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	38.36	9.40	2.00	0.31	2.77	0.62	1.08	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.08	11.25	3.68	0.61	3.89	1.23	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.16	6.26	4.38	0.94	1.25	0.31	0.63	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	19.21	7.63	4.52	1.13	2.26	0.00	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	8.30	3.69	0.00	1.38	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	4.95	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	21.27	5.03	0.77	1.55	1.16	0.39	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	6.42	0.00	4.81	1.60	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	8.69	3.48	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	19.85	5.21	3.58	1.63	1.63	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	20.59	8.65	2.88	0.00	0.82	0.00	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.41	5.03	2.24	0.00	0.56	0.56	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	21.90	6.86	4.25	0.65	0.33	0.98	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	21.81	5.03	6.71	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	27.04	7.63	2.23	0.00	1.27	0.64	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	22.08	3.40	0.68	0.34	0.34	0.34	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	4.18	4.18	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	30.93	4.58	1.72	1.15	0.57	0.57	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.42	5.03	3.85	2.07	0.59	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	6.78	5.08	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.23	7.46	6.21	0.83	0.83	1.66	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.48	5.52	4.37	0.00	0.92	0.92	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	5.38	2.31	0.00	1.54	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	16.62	5.22	1.63	0.33	1.63	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	5.35	4.01	0.67	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	22.73	3.47	2.70	0.00	1.16	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.69	7.87	3.77	0.68	0.68	1.03	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	4.97	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.48	2.36	5.19	0.47	0.00	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.14	4.22	6.64	0.00	1.21	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.36	1.02	3.56	0.00	0.51	1.02	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.94	1.99	1.60	1.20	0.80	0.40	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	2.47	1.97	0.00	0.00	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	4.72	3.54	1.18	1.18	0.00	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	2.92	1.17	0.00	0.58	0.00	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	18.43	3.95	2.19	0.88	0.44	0.44	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	8.48	3.39	0.85	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.12	1.79	2.39	0.60	0.60	1.19	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	3.88	5.34	0.00	0.00	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	5.71	0.00	1.14	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	3.74	6.24	1.25	1.25	2.08	0.42	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	12.37	2.25	3.37	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.49	11.10	4.44	1.27	1.59	1.90	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	11.70	4.60	1.25	2.09	1.25	0.42	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	1.51	15.32	0.35	3.95	1.04	0.00	0.12	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.03	14.01	0.17	4.05	0.51	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.96	17.52	0.00	5.46	0.46	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2.95	13.77	0.00	5.14	0.66	0.00	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	2.79	18.91	0.00	3.65	1.07	0.00	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1.94	12.70	0.00	3.23	0.86	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.62	13.95	0.00	3.24	0.62	0.12	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.06	12.18	0.00	1.89	0.51	0.17	0.00	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.92	16.34	0.00	3.52	1.28	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	14.55	1.68	0.00	1.12	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	14.28	7.79	1.30	2.60	0.43	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	5.29	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	19.40	4.59	4.23	0.71	1.06	0.71	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.07	7.99	1.45	1.45	1.45	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.97	4.37	1.22	0.87	1.22	0.00	0.17	0.35
Hepatocyte, donor1	11523-119I2	15.74	2.42	2.42	3.63	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	5.39	2.15	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	12.27	6.75	3.68	0.00	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	12.40	34.59	0.65	3.26	0.65	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.22	19.05	4.19	2.97	1.75	1.40	0.17	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	5.49	3.02	1.10	0.14	0.55	0.14	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	19.10	3.18	3.18	0.00	0.00	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	20.03	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	16.61	2.77	1.38	4.15	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	17.52	5.01	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	35.60	11.87	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	41.01	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	22.85	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	32.49	3.25	3.25	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	21.67	3.33	6.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	14.52	3.63	0.00	3.63	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	27.79	1.32	1.32	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	16.63	1.11	0.00	2.22	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	20.95	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.68	24.56	2.52	1.26	0.63	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	15.47	1.55	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	21.97	1.94	0.65	2.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	32.20	3.22	3.22	0.00	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	23.90	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	26.89	27.71	0.81	3.26	2.44	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	24.77	19.31	4.20	3.36	1.68	0.00	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	43.12	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	22.50	3.21	1.61	4.02	0.80	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	21.24	11.08	1.85	2.77	2.77	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	45.24	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	19.35	3.78	2.36	1.42	0.00	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	19.05	1.81	1.81	0.91	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	22.60	2.15	4.30	3.23	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	21.60	3.81	2.54	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.25	15.94	4.46	4.46	1.91	0.00	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	30.99	0.00	3.65	3.65	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	15.80	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.28	22.85	2.14	3.57	2.86	0.00	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	16.59	3.32	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	62.55	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	12.96	2.47	3.40	3.70	0.31	0.93	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	26.34	1.76	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	28.29	3.14	6.29	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	20.17	2.78	4.17	3.48	0.70	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	28.77	4.43	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	22.69	0.00	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.03	22.67	0.87	3.49	1.74	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	11.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	17.42	0.00	0.00	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	33.07	9.60	5.33	0.00	4.27	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	18.01	4.16	1.39	2.77	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	22.80	2.85	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	18.41	19.33	1.84	5.52	4.60	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	18.15	3.03	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	24.83	6.21	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	15.86	3.17	4.23	3.17	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	14.36	4.32	1.71	1.22	0.90	0.41	0.24	0.24
Keratinocyte - epidermal, donor2	11349-117G8	12.88	8.20	0.59	1.17	3.51	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.02	8.14	2.27	1.14	1.51	0.38	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	32.01	9.42	4.99	1.36	2.61	1.70	0.68	0.57
Keratocytes, donor1	11527-119I6	25.79	2.06	2.75	0.34	1.72	1.38	0.00	0.00
Keratocytes, donor2	11607-120I5	23.44	8.20	2.34	0.00	3.52	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	26.48	5.53	2.17	1.19	2.17	1.19	0.20	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	6.59	0.00	0.00	0.00	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	10.79	7.55	1.08	1.08	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.19	3.46	1.38	0.58	0.23	0.12	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	7.47	2.32	0.81	0.30	0.30	0.50	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.18	4.15	0.59	0.71	1.07	0.12	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.42	2.23	0.56	0.28	1.67	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.19	4.56	0.63	1.42	1.73	0.16	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	3.76	0.54	1.61	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.56	1.89	0.32	0.32	0.95	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.49	2.80	0.22	1.40	0.54	0.00	0.54	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	2.87	0.00	0.82	1.64	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.33	3.54	0.25	0.51	1.26	0.00	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.46	2.82	0.28	1.27	0.84	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.75	2.37	0.40	0.00	0.40	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	3.88	0.19	0.19	0.58	0.19	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	2.59	0.56	0.74	0.56	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	7.67	1.74	0.00	0.35	0.70	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.20	1.91	0.48	1.19	0.95	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.69	3.57	0.27	0.69	0.96	0.55	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.39	2.16	0.31	0.31	0.62	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.35	3.43	0.31	0.62	0.94	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.60	3.11	0.73	0.91	0.91	0.00	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.89	3.95	0.33	0.33	0.99	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	7.32	0.29	2.05	0.88	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.97	2.49	0.75	1.00	1.24	0.25	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	2.42	1.94	1.94	0.97	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	2.42	0.54	0.81	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	2.72	0.76	1.06	1.06	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	2.07	0.52	1.04	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.44	4.61	1.47	1.05	1.26	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.87	1.95	0.90	0.15	0.90	0.00	0.90	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.82	4.82	0.00	1.38	2.06	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.08	3.95	0.75	0.75	0.56	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.74	2.97	0.74	0.64	1.17	0.11	0.53	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	3.39	0.00	1.45	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	1.98	0.99	0.66	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.80	2.48	0.12	0.50	0.62	0.12	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	2.96	0.00	2.59	0.37	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.67	3.95	0.00	0.74	0.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	1.79	0.41	0.69	0.96	0.27	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.79	3.54	0.32	0.00	0.96	0.00	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.09	3.65	0.61	0.91	1.52	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.70	1.96	0.98	0.70	1.40	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	3.91	0.36	1.42	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	3.39	0.00	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.22	2.02	0.93	0.78	0.78	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	3.22	0.00	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	5.23	0.98	0.65	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.36	2.35	0.00	1.88	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.91	3.96	0.87	2.35	0.99	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.94	2.31	0.26	1.28	1.02	0.51	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	2.39	0.60	0.60	0.90	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	104.24	18.13	15.86	4.53	2.27	6.80	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	145.76	16.11	19.95	2.30	8.44	6.90	1.53	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	100.94	20.78	16.33	2.23	3.71	2.97	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	124.40	18.19	19.04	3.81	9.31	5.92	1.69	4.65
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	147.70	19.69	19.69	2.11	7.74	6.33	1.41	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	127.95	14.01	14.94	1.87	10.27	0.93	2.80	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	105.63	16.49	15.46	1.55	13.91	5.15	1.03	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	120.14	16.65	7.14	8.33	4.76	3.57	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	124.86	19.90	18.77	4.98	7.01	4.07	2.04	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	97.43	16.58	12.80	1.74	5.82	3.49	2.33	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	109.39	20.71	16.21	2.70	6.75	5.85	1.35	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	147.00	23.30	22.08	3.93	9.75	6.10	2.57	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	108.87	21.57	14.89	5.65	5.14	9.24	1.03	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	133.38	17.29	14.82	3.53	7.76	3.18	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	82.62	13.99	10.66	2.00	5.33	3.33	1.33	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	123.27	13.75	17.83	4.58	4.58	6.62	2.04	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	127.80	18.41	19.48	2.40	6.40	4.00	1.60	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	114.12	19.46	17.19	2.83	6.80	4.16	1.32	3.59
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	109.21	12.88	20.25	6.75	7.36	5.52	1.23	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	120.68	19.57	17.94	6.52	17.12	3.26	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	108.70	14.58	19.57	3.12	6.87	4.79	1.04	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	90.80	14.57	21.02	1.68	3.64	7.29	2.24	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	143.22	11.33	21.64	5.15	4.12	7.21	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	114.38	14.52	19.45	3.48	8.42	4.35	0.87	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	92.37	10.46	17.04	1.20	5.68	3.59	0.90	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	95.71	13.83	19.36	2.77	6.09	4.98	0.55	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	108.17	19.44	23.33	3.53	6.36	4.24	0.35	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	84.45	13.28	16.96	2.95	7.01	4.79	1.48	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	95.56	19.57	14.97	1.15	5.76	4.61	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	132.01	22.26	16.50	2.30	10.75	2.30	1.92	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	104.73	17.55	15.29	5.66	7.36	7.93	1.13	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	102.56	13.95	17.23	4.10	8.20	2.46	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	108.90	21.24	18.53	3.62	4.07	5.42	2.71	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	117.06	16.52	21.54	3.59	6.46	3.59	1.44	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	146.39	16.43	20.17	1.49	6.72	2.99	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	129.31	18.95	23.04	7.06	8.55	5.95	1.49	9.66
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	96.92	17.23	13.35	1.72	5.17	3.02	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	139.58	17.98	9.42	1.71	6.85	3.43	1.71	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	126.61	20.32	15.33	3.66	9.66	4.66	3.00	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	98.94	27.15	20.51	4.83	8.45	4.22	1.21	4.83
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	118.74	19.91	24.88	1.42	4.27	3.55	3.55	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	107.93	18.22	19.25	3.44	7.22	4.81	2.06	5.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	87.49	23.08	15.57	3.76	4.29	5.90	1.61	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	131.98	40.40	22.22	4.71	6.06	2.69	1.35	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	122.23	23.71	21.11	4.44	7.78	5.19	0.74	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	93.03	15.12	11.63	2.33	3.49	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	123.76	28.56	23.27	5.29	9.52	4.23	0.00	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	122.05	24.81	20.81	4.00	8.40	5.20	2.40	4.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	111.21	13.81	17.44	2.18	3.63	7.27	1.45	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	168.63	23.76	19.93	1.53	3.07	5.37	0.00	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	139.60	27.13	26.64	3.95	8.88	3.95	3.45	6.91
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	97.86	29.17	16.00	5.65	5.65	4.70	1.88	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	183.03	24.64	26.15	1.01	6.03	6.03	3.52	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	141.95	17.57	16.22	1.35	7.21	2.25	1.80	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	86.06	15.49	6.88	0.00	1.72	6.88	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	133.16	23.60	17.81	4.45	5.34	8.46	4.01	4.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	126.69	17.60	17.21	3.91	3.91	4.69	1.56	5.47
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	85.77	11.22	7.26	5.28	4.62	6.60	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	145.82	16.61	17.12	2.59	8.82	5.71	1.56	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	154.02	21.44	14.88	3.50	8.31	5.25	1.31	6.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	98.40	15.10	14.54	1.68	8.95	6.71	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	147.95	22.08	15.90	5.30	5.74	6.62	0.44	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	126.13	16.59	17.74	2.31	7.71	4.24	1.16	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	90.64	10.63	13.17	3.04	4.56	3.04	2.03	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	115.83	21.63	17.78	4.81	3.36	5.77	1.92	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	106.54	20.67	16.30	4.37	6.36	3.98	1.19	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	88.71	18.23	12.15	5.47	3.04	4.25	1.22	4.86
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	87.85	14.53	9.68	0.69	4.15	2.77	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	121.22	18.24	19.00	1.90	4.94	6.46	1.90	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	87.79	17.56	19.62	2.07	5.68	3.10	1.55	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	104.00	18.74	17.53	1.21	4.84	3.02	0.00	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	119.15	22.18	18.06	2.54	8.24	5.39	2.54	5.39
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	93.29	18.13	15.99	2.13	9.06	4.26	3.20	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	104.02	19.54	10.34	4.60	5.17	1.72	1.15	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	105.42	22.63	18.51	4.11	6.69	4.63	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.98	28.29	16.98	3.54	7.07	4.95	4.24	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	116.33	19.29	9.65	1.70	9.65	2.84	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	126.06	18.72	15.81	2.91	6.24	6.66	1.66	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	86.13	15.66	6.26	7.05	6.26	3.13	2.35	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	113.57	15.87	17.95	1.25	4.18	4.18	1.67	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	118.95	23.23	19.98	0.93	6.04	4.65	1.39	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	88.31	15.39	15.39	2.01	8.03	6.02	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	105.86	16.04	12.30	3.21	7.48	4.28	1.60	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	113.55	26.67	20.20	3.64	7.27	4.45	2.42	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	88.11	19.27	15.60	0.92	4.59	3.67	0.00	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	97.80	18.67	12.45	1.78	5.33	14.23	2.67	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	116.82	15.39	17.10	6.84	7.41	3.99	1.14	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	85.13	19.94	18.41	2.30	6.90	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	85.91	20.25	15.87	3.28	9.30	2.74	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	118.49	24.05	23.61	4.01	8.46	3.56	1.34	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	127.90	22.62	22.62	6.24	6.24	3.38	1.30	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	114.72	25.20	17.90	2.65	7.29	3.98	2.65	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	99.77	24.94	31.18	2.08	6.24	4.16	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	6.38	12.08	0.00	2.28	1.82	0.00	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	3.85	5.51	0.92	0.92	2.20	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	7.86	8.65	0.92	1.97	3.93	0.00	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.31	2.66	0.53	2.66	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	5.70	3.33	0.32	0.63	0.32	0.48	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	6.25	4.86	0.69	0.83	0.69	0.28	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	13.75	3.39	1.79	0.60	1.20	1.00	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	21.14	4.05	2.61	0.58	2.03	1.45	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	16.71	5.24	1.75	1.00	1.00	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1.36	1.36	0.00	0.00	0.68	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	8.22	22.93	0.22	2.92	1.62	0.11	0.00	0.11
Mast cell, donor2	11565-120D8	9.21	23.18	0.59	2.67	1.49	0.00	0.59	0.00
Mast cell, donor3	11566-120D9	7.43	31.74	0.23	4.05	1.35	0.00	0.23	0.45
Mast cell, donor4	11567-120E1	5.50	32.09	0.89	1.60	0.53	0.00	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	4.88	21.40	0.67	2.44	0.89	0.00	0.22	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	1.17	29.77	0.00	7.00	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	6.65	31.89	0.46	4.36	0.69	0.23	0.46	0.34
Mast cell, expanded, donor8	11941-126A6	5.69	42.68	0.67	6.03	0.84	0.00	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	10.94	3.78	0.80	1.49	2.19	0.60	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	9.34	3.81	3.46	0.69	1.73	0.35	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	21.15	7.82	1.96	1.38	1.52	0.22	0.43	0.07
Melanocyte - light, donor1	11274-116H5	14.10	4.23	1.41	0.47	1.65	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	20.47	6.14	3.41	0.68	2.05	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	11.27	5.20	2.60	1.73	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.56	13.74	1.25	1.04	1.35	0.10	0.31	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	9.68	6.99	1.34	1.08	1.61	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	21.96	7.77	3.21	1.34	1.07	0.54	1.07	0.54
Meningeal Cells, donor1	11493-119E8	20.47	6.82	0.50	0.74	1.49	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	12.76	5.72	0.44	0.44	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	9.78	6.36	0.90	1.47	1.14	0.16	0.65	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	18.54	5.13	3.14	1.14	2.00	0.86	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.22	3.22	0.91	0.81	0.30	0.20	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	90.68	7.88	21.03	5.26	5.26	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	10.47	9.16	0.00	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.96	5.02	1.44	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.41	2.12	1.27	0.42	0.85	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.54	1.51	0.00	0.00	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.60	9.01	2.20	0.44	2.20	0.44	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	14.61	13.15	2.92	2.92	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	14.73	8.39	1.43	1.64	0.20	0.61	1.02	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.88	4.43	0.83	1.25	0.97	0.83	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	42.38	8.92	5.58	1.49	2.97	2.60	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.10	5.66	3.68	0.79	0.92	0.39	0.13	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	40.06	11.87	6.53	2.37	3.86	6.83	0.30	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	2.34	2.34	2.34	0.00	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	7.68	4.48	0.64	0.00	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.30	4.25	3.54	3.54	1.77	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.76	7.19	1.88	0.94	1.25	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	17.42	7.98	3.63	1.45	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	3.98	9.02	0.53	1.33	0.80	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	4.50	5.51	0.50	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	4.62	7.23	0.29	0.65	0.29	0.22	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	4.05	0.00	0.00	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	3.69	10.10	0.49	1.23	0.74	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.01	5.01	0.59	1.77	2.36	0.00	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.86	9.61	0.31	1.86	1.55	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.73	7.05	0.83	1.24	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	2.50	9.01	0.75	2.00	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.79	6.52	1.40	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	2.24	11.18	0.00	1.63	1.63	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.17	6.73	0.00	1.58	3.17	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	10.62	0.00	0.88	0.00	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	5.32	8.74	0.38	1.14	1.52	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	2.63	1.32	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.40	8.28	0.64	1.27	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	3.68	1.84	0.92	2.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.38	4.77	0.00	0.60	0.89	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.51	5.77	0.25	0.75	0.25	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.57	4.52	0.71	1.19	0.95	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	7.74	0.55	2.21	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.84	4.14	0.00	0.69	1.15	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.26	5.05	0.21	1.68	1.05	0.00	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.43	3.87	0.61	0.00	1.63	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.72	4.29	0.43	0.43	0.64	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.00	4.89	0.44	0.67	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.53	3.72	0.00	0.22	0.88	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	3.04	0.00	0.51	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	3.31	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.54	4.35	0.00	0.54	0.82	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.65	4.71	0.00	0.59	1.47	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	3.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.96	4.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1.60	4.00	1.20	0.00	2.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	12.34	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.50	8.01	0.00	1.00	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.88	6.13	0.00	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	2.21	1.10	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	8.97	0.00	0.00	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.98	6.20	0.25	1.98	0.99	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	6.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	8.84	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.39	8.89	0.00	1.03	2.05	0.00	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	3.94	0.00	0.88	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.55	4.97	0.36	0.00	3.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.52	8.42	0.00	1.40	3.65	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	6.23	0.42	0.42	5.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	5.83	1.17	0.00	2.33	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	8.75	0.00	1.51	3.32	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	6.26	0.42	1.25	3.34	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	7.39	0.00	0.00	3.69	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.41	5.12	0.57	2.28	3.41	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.11	5.67	0.00	0.83	2.49	0.28	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.85	6.48	0.26	0.52	4.15	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.58	5.15	0.00	0.86	3.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	4.45	0.00	0.64	3.81	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.27	7.74	0.27	0.53	5.07	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.59	10.18	0.60	0.90	2.10	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.39	5.65	0.00	1.27	2.26	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.82	4.46	0.00	0.96	2.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.86	8.62	0.44	1.11	5.97	0.44	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	5.69	0.00	2.28	1.90	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1.42	7.39	0.00	1.42	2.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	2.95	9.09	0.25	2.70	3.44	0.25	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	8.47	0.00	1.30	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.17	9.41	0.00	1.18	4.12	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.19	11.24	0.29	1.73	3.46	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.89	6.59	0.00	0.41	2.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	12.21	0.89	1.19	3.28	0.00	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	18.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	3.56	0.00	1.78	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	12.81	0.99	1.97	2.63	0.33	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	8.42	2.10	2.10	4.21	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.97	8.90	0.00	1.78	1.19	0.20	0.79	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	5.59	0.00	0.00	0.93	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.89	9.01	0.38	0.38	1.88	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.59	11.45	0.53	2.13	1.07	0.00	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.51	8.93	0.23	1.36	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	8.10	0.00	2.95	0.74	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.76	7.69	0.37	1.10	1.10	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	9.33	1.56	4.67	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	6.95	0.00	1.07	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	15.46	0.00	0.00	3.86	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	5.05	7.07	1.01	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	4.22	1.26	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	5.45	0.00	5.45	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	1.51	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	51.39	0.00	11.42	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	22.84	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	37.65	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	6.25	3.45	0.43	0.22	0.65	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.14	3.66	0.00	1.57	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	0.67	5.34	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	2.09	2.50	0.42	0.83	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.85	2.09	0.57	0.38	0.57	0.19	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	0.00	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	0.68	2.72	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	1.26	2.09	0.42	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.83	2.32	1.39	0.23	1.63	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	2.16	3.24	0.54	1.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.04	3.57	1.89	0.00	1.47	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	1.49	4.96	0.99	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	4.60	1.62	0.81	1.08	1.62	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.39	2.49	1.36	1.13	0.91	0.23	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.82	1.31	2.78	0.33	1.14	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.02	3.10	1.64	0.18	0.91	0.36	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	1.59	2.65	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	0.60	6.00	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.25	0.00	0.33	0.00	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	1.30	0.98	0.81	0.16	0.33	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.76	2.65	2.12	0.35	1.23	0.18	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	2.81	2.81	1.41	0.70	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	2.30	3.22	0.46	0.92	0.92	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.68	2.25	2.89	0.64	1.29	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.45	0.69	1.38	1.03	0.00	0.34	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	0.00	0.00	0.00	0.00	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.02	2.23	1.11	0.89	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	1.27	0.42	0.85	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.22	1.42	1.90	0.95	1.42	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	2.15	4.29	1.29	0.43	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	4.67	3.33	1.67	0.33	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.06	1.35	0.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	0.79	1.98	0.40	0.40	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	1.86	3.71	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.95	2.27	1.14	0.76	0.38	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	3.58	2.28	2.28	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	7.84	1.74	3.49	0.00	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.43	4.98	0.90	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	0.88	3.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	0.66	5.32	0.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	2.98	2.98	1.49	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	0.38	2.68	0.38	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.19	4.84	0.60	0.91	1.21	0.00	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	4.64	1.77	1.11	0.22	1.33	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	2.03	2.71	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	4.88	4.88	0.00	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	2.20	1.26	0.00	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	1.82	2.42	0.61	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	4.75	1.58	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3.40	2.27	1.13	0.00	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.10	5.22	1.49	0.37	0.87	0.50	0.12	0.12
Myoblast, donor2	11322-117D8	13.62	4.60	4.41	0.58	0.77	0.19	0.00	0.58
Myoblast, donor3	11398-118D3	10.59	3.20	2.19	1.01	0.67	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.20	71.22	1.90	5.55	0.44	0.73	0.44	0.73
Natural Killer Cells, donor1	11230-116C6	6.15	43.97	0.62	1.23	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	3.32	40.41	0.30	2.41	0.30	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	5.89	49.33	0.37	1.29	0.37	0.18	0.00	0.00
Neural stem cells, donor1	11275-116H6	2.18	1.09	0.36	0.36	1.09	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	9.63	0.00	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	4.55	3.41	0.00	0.00	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	5.72	1.98	0.22	0.00	0.66	0.00	0.00	0.00
Neurons, donor3	11655-122E8	0.82	3.29	0.82	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	36.19	0.00	3.71	0.00	0.00	0.00	1.86
Neutrophils, donor2	11314-117C9	0.00	49.28	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	37.26	0.00	2.44	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	28.02	3.44	2.97	2.02	2.85	1.66	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	25.40	2.93	4.56	0.33	1.30	2.28	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	13.64	3.01	0.60	0.00	0.20	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	8.12	1.65	2.48	0.28	0.96	0.28	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	8.40	1.74	1.45	0.58	0.43	0.00	0.43	1.01
Olfactory epithelial cells, donor3	11935-125I9	7.83	3.18	1.02	1.02	1.36	0.11	0.34	0.11
Olfactory epithelial cells, donor4	11936-126A1	4.97	5.16	1.66	1.27	0.97	0.19	0.49	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	11.43	2.41	2.41	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	7.23	2.98	1.06	1.28	0.64	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	6.86	0.00	2.29	2.29	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	5.59	3.10	0.00	1.24	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	13.68	3.52	2.74	0.39	0.59	0.39	0.00	0.59
Osteoblast, donor2	11354-117H4	9.13	1.40	1.40	0.00	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	12.97	5.33	3.02	1.07	0.71	0.18	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	11.96	3.96	1.26	1.01	0.93	0.17	0.08	0.34
Pericytes, donor1	11491-119E6	27.04	6.01	2.34	0.78	1.00	0.78	0.45	0.11
Pericytes, donor2	11571-120E5	17.88	5.66	1.81	0.23	1.58	0.45	0.00	0.45
Pericytes, donor3	11652-122E5	12.21	7.73	1.83	0.61	1.42	0.41	0.00	0.61
Perineurial Cells, donor1	11499-119F5	13.45	7.12	1.36	0.45	0.79	0.34	0.34	0.00
Perineurial Cells, donor2	11579-120F4	14.63	5.52	2.21	0.74	1.20	0.18	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.71	21.67	0.32	1.59	1.91	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.24	23.02	0.98	0.49	1.22	0.24	0.00	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.15	26.14	0.52	0.78	1.04	0.13	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	14.59	23.20	1.20	1.67	1.91	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	12.20	14.42	3.33	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.93	16.88	3.34	3.34	1.37	1.96	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.91	3.16	0.95	0.95	0.95	0.63	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	5.06	3.94	0.75	0.94	1.69	0.75	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.83	6.00	0.91	1.83	0.91	0.00	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	10.81	6.53	1.58	0.90	0.90	0.45	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	5.65	5.54	0.85	1.39	0.43	0.32	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	6.11	4.80	0.87	0.44	0.87	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	7.02	5.30	1.00	0.57	0.86	1.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	8.86	7.87	1.97	0.00	0.00	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.06	2.76	4.61	1.54	0.92	0.92	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	11.51	7.44	3.36	2.48	1.24	0.18	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	14.30	5.79	6.47	0.85	0.68	0.17	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	13.04	4.10	3.17	1.49	0.65	0.47	0.47	0.00
Preadipocyte - visceral, donor2	11357-117H7	6.90	6.90	0.00	0.46	0.92	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.46	4.49	1.99	0.63	0.94	0.31	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	24.14	13.28	4.68	1.36	1.21	1.06	0.30	0.30
Prostate Epithelial Cells, donor2	11331-117E8	5.42	3.66	0.54	0.95	0.81	0.41	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	8.08	2.20	1.90	0.43	0.31	0.06	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	7.52	3.42	2.39	0.80	0.23	0.23	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	9.68	4.66	1.43	0.72	0.72	0.00	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	10.43	5.21	1.25	0.63	0.52	0.31	0.42	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.44	10.58	2.92	1.46	2.55	0.73	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.21	10.47	0.55	0.97	0.62	0.07	0.21	0.21
Renal Epithelial Cells, donor1	11517-119H5	30.43	13.70	1.52	1.01	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.80	14.23	1.42	2.85	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.05	10.59	0.42	1.06	0.53	0.11	0.42	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.19	6.13	0.68	0.68	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.40	6.06	1.08	0.81	1.35	0.00	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.10	5.55	0.89	1.55	1.78	0.22	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.96	5.32	0.00	0.67	2.00	0.67	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.11	11.22	1.54	1.32	0.88	0.44	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	25.08	5.64	1.25	0.63	2.51	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	20.25	7.21	1.94	1.11	2.50	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.49	18.79	2.15	3.76	2.42	0.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	14.34	0.00	1.69	2.11	0.00	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.27	13.50	0.58	1.35	1.35	0.77	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.70	7.00	0.78	1.81	0.52	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	17.34	6.25	1.71	0.57	0.57	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	9.26	2.06	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.77	3.26	0.25	0.25	0.75	0.00	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.04	18.58	1.47	2.67	2.00	0.40	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	23.23	18.76	0.89	1.79	0.00	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	4.95	6.60	0.55	3.85	0.55	0.00	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	14.50	14.50	0.58	1.16	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.58	14.56	0.78	1.17	2.47	0.00	0.52	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.84	18.87	3.28	1.89	2.78	0.10	0.20	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.78	18.96	3.23	3.79	2.34	0.22	0.45	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.68	21.83	1.61	2.60	3.23	0.25	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	28.32	17.13	3.15	3.73	2.56	0.23	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.74	20.57	1.62	3.47	3.00	0.46	1.39	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.80	16.16	0.68	1.10	1.51	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.20	19.97	1.82	2.72	1.51	0.45	1.06	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.73	22.40	3.94	2.87	3.23	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	18.22	20.08	2.87	1.86	2.44	0.43	0.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.00	17.60	2.36	3.65	3.33	0.54	1.07	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.22	23.90	3.54	3.10	2.43	0.66	1.11	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.49	16.82	2.10	1.72	0.57	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.20	18.63	3.35	2.70	2.05	0.19	1.02	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	26.31	20.11	1.88	3.38	2.44	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	18.18	15.26	1.73	1.46	1.06	0.66	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.11	18.40	3.89	2.43	2.43	0.19	0.49	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.63	15.85	2.48	2.48	1.72	0.57	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	21.57	17.41	1.39	2.14	1.28	0.11	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	17.38	4.20	3.36	2.24	0.00	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.73	14.87	2.22	3.08	2.91	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.86	17.50	1.64	1.64	1.28	0.55	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.55	18.27	3.80	1.47	1.59	0.12	0.61	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.80	21.89	3.09	3.36	3.22	0.40	1.21	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.58	20.29	1.89	1.42	0.71	0.24	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.98	13.49	1.39	1.39	1.98	0.00	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.62	22.22	3.74	2.34	2.10	0.00	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.04	20.94	3.53	2.07	1.45	0.00	0.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.47	15.48	2.21	2.65	2.43	0.22	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	22.98	15.67	1.67	3.13	1.88	0.21	1.04	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.40	21.67	1.62	1.35	2.29	0.13	0.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.48	14.82	2.38	2.21	2.55	0.17	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.21	16.39	4.43	2.70	1.54	0.19	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.47	23.21	1.89	1.89	1.38	0.52	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	24.83	13.85	2.74	2.33	2.19	0.27	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.03	15.92	1.81	4.10	1.81	0.00	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	16.87	18.75	2.90	3.07	1.02	0.00	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.67	17.75	3.26	2.66	2.96	0.44	0.89	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.39	14.93	3.73	3.73	2.93	0.00	0.80	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.39	13.00	1.52	1.24	1.11	0.14	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	31.43	17.86	2.38	4.29	2.62	0.48	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	22.77	19.75	2.62	2.02	2.42	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.55	19.78	1.41	1.70	1.51	0.38	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.11	17.12	2.79	3.14	1.40	0.00	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	16.92	12.09	1.51	1.81	0.91	0.00	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.89	23.13	1.84	2.33	1.71	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	25.76	20.23	2.77	3.06	1.89	0.44	0.73	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	12.78	3.04	3.65	0.61	0.00	1.22	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.86	19.59	3.92	1.51	1.21	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.31	23.52	3.17	2.04	2.71	0.23	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.86	19.17	6.89	3.00	1.80	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.84	21.61	1.06	2.48	1.65	0.24	0.47	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.55	23.48	2.99	2.13	3.20	0.21	1.07	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	15.63	21.03	4.81	3.00	2.40	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	25.20	8.09	1.69	1.13	1.69	0.19	0.38	0.00
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.61	4.82	2.41	0.66	1.75	0.22	0.66	0.22
Sebocyte, donor1	11220-116B5	14.24	7.12	2.19	1.64	0.55	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	15.17	4.60	2.30	0.00	0.46	0.92	0.46	0.00
Sebocyte, donor3	11378-118B1	25.56	12.57	4.12	1.03	1.24	0.41	0.62	0.21
Sertoli Cells, donor1	11255-116F4	8.28	6.63	0.00	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	5.65	0.00	2.82	0.00	0.00	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	13.81	4.40	1.85	0.97	0.88	0.26	0.62	0.18
Skeletal Muscle Cells, donor2	11358-117H8	9.40	2.17	0.72	0.72	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	18.39	4.18	3.34	0.84	1.67	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	21.68	6.60	4.56	1.41	1.10	1.89	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	29.28	5.20	7.58	0.15	2.68	0.59	0.30	0.59
Skeletal Muscle Cells, donor6	11459-119B1	14.62	3.69	4.00	1.54	0.46	0.31	0.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	53.17	7.69	8.44	1.01	2.65	3.53	0.25	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	52.94	6.71	15.84	0.29	2.00	2.43	0.14	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.64	5.46	5.85	0.69	1.49	0.50	0.30	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.19	4.04	1.94	0.76	0.51	0.34	0.42	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	2.90	3.62	0.72	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.90	3.58	2.20	1.38	1.10	0.96	0.28	0.14
Skin - palm, donor1	10286-104F7	59.09	5.37	8.06	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.65	5.33	1.15	0.72	0.86	0.29	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	7.36	0.00	0.00	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.65	2.73	2.34	0.52	0.39	0.26	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.67	4.03	0.70	0.56	0.70	0.00	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	8.02	2.95	1.41	0.00	0.84	0.14	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.72	12.69	1.69	2.75	2.96	1.27	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	8.39	3.97	1.80	0.30	0.07	0.00	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.01	3.39	1.85	1.54	0.93	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.45	5.34	0.22	0.67	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	4.11	2.35	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.56	3.54	1.33	1.77	0.66	0.66	0.00	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.81	5.91	1.58	0.79	0.39	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	8.50	1.55	0.77	0.77	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	37.03	7.01	7.01	1.00	3.00	2.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.59	3.86	1.46	0.40	0.00	0.13	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.64	3.10	2.44	0.89	1.33	0.22	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.38	4.99	1.79	0.90	0.51	0.13	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.14	1.63	0.65	0.65	0.65	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.16	4.13	1.48	0.00	0.59	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.40	5.69	1.57	0.85	0.57	0.14	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	20.01	6.02	4.07	1.30	1.63	0.81	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.88	8.22	4.26	0.61	0.61	1.22	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.66	3.79	1.77	1.01	2.02	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	30.60	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	3.81	1.43	0.48	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	10.47	2.80	0.59	0.44	0.59	0.59	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.19	3.01	3.23	0.65	0.86	0.22	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.90	4.62	3.46	0.63	0.94	0.52	0.42	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.29	3.40	1.24	2.47	1.39	0.15	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	2.16	1.08	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.48	3.89	0.90	1.49	0.90	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	25.26	8.19	3.07	1.71	0.00	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.12	4.63	4.95	1.10	1.96	1.41	0.47	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	5.23	4.33	0.60	0.60	0.40	0.70	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.24	6.14	0.46	1.59	0.91	0.23	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	3.62	0.00	0.60	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	10.07	9.54	1.59	1.59	1.06	0.53	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	11.72	3.06	1.33	0.27	1.20	0.67	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.90	3.01	2.13	0.75	1.00	0.88	0.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.34	2.79	0.51	0.00	0.25	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.93	4.67	3.32	1.06	1.06	0.15	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	13.50	4.50	0.00	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	90.46	6.46	6.46	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.70	5.12	0.00	0.93	1.40	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.07	3.03	1.01	2.02	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.07	4.39	0.94	0.31	0.63	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	6.78	5.01	0.88	1.18	2.36	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	20.66	3.33	2.67	1.08	1.83	0.58	0.42	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	31.77	7.94	5.14	1.40	3.74	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.47	4.61	1.44	0.72	0.29	0.14	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.73	4.84	1.27	0.51	0.76	0.51	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.34	3.20	2.82	0.94	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.24	6.43	1.12	1.82	0.56	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.72	7.71	1.09	0.50	1.09	0.25	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	5.71	1.43	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.34	5.14	0.98	0.98	0.00	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.18	4.20	1.33	1.33	0.88	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.48	7.31	0.29	1.17	1.17	0.00	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.50	4.08	2.33	1.17	1.55	0.00	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2.12	3.97	0.00	1.59	0.00	0.26	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.98	1.12	0.74	0.37	0.74	0.00	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.03	4.31	0.36	0.00	1.08	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.26	2.84	0.57	0.57	0.85	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	3.54	1.18	0.79	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	7.36	3.56	0.76	0.76	0.25	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	6.39	7.59	1.60	0.00	1.20	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	4.18	0.84	1.67	0.42	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.17	6.42	1.38	0.92	1.38	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	5.89	2.86	0.17	0.50	0.00	0.50	0.34	0.17
Synoviocyte, donor2	11368-117I9	14.92	3.52	3.35	1.17	0.67	0.50	0.17	0.34
Synoviocyte, donor3	11440-118H9	12.29	3.35	1.79	0.89	2.01	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	32.16	12.86	3.93	2.14	3.57	0.71	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	35.68	5.95	0.00	1.98	3.96	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	31.03	9.26	2.55	1.62	2.78	1.16	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	13.05	3.51	1.43	0.50	0.86	0.29	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	15.85	4.64	2.71	0.77	0.77	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	4.01	2.29	0.00	1.15	0.00	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.72	14.64	1.60	2.34	2.21	0.37	0.86	0.62
Urethra, donor2	10319-105A4	14.39	10.79	3.60	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	11.16	12.22	1.86	1.06	0.80	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	15.62	7.21	1.60	2.00	0.80	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	9.86	11.69	1.38	2.98	0.46	0.46	0.46	0.23
Urothelial cells, donor0	11216-116B1	7.13	13.82	1.34	2.67	0.67	0.22	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	60.51	0.89	4.45	0.00	0.00	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	64.33	0.00	5.72	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	41.76	0.00	2.05	0.00	0.00	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	4.48	38.57	0.69	3.10	1.03	0.34	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.65	35.44	0.00	2.91	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	5.21	54.14	0.00	3.12	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1.84	49.56	0.00	0.92	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	24.65	0.00	5.48	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	26.28	3.45	4.69	0.86	1.11	0.25	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	13.20	0.00	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	29.05	13.13	3.91	3.07	2.23	1.12	0.00	0.28
achilles tendon, donor2	10292-104G4	14.47	8.27	0.00	0.00	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.10	27.79	2.04	2.04	0.51	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.65	32.50	3.71	3.25	1.16	0.46	0.70	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.30	30.39	1.78	3.44	0.00	0.12	0.24	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	23.40	28.84	2.72	5.44	0.82	0.54	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.61	42.72	1.97	1.69	1.97	0.56	1.41	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.09	61.75	1.90	7.19	1.90	0.00	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	13.34	0.82	1.63	1.09	1.36	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.05	19.83	3.97	1.32	3.53	3.97	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	47.78	1.23	2.86	1.23	0.82	1.63	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	48.93	48.93	8.15	6.99	4.66	0.78	1.94	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	27.42	25.76	2.21	2.76	1.84	1.10	0.37	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	19.50	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.82	14.18	1.86	1.63	3.72	0.70	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	43.24	2.33	4.14	2.59	0.00	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	15.78	29.22	1.46	2.92	2.34	0.00	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.55	20.91	0.93	1.86	1.86	0.46	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.86	21.39	1.65	3.70	3.70	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	28.24	8.90	4.60	0.92	1.23	0.31	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.43	7.25	1.71	2.13	0.85	0.43	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.78	13.34	1.21	2.12	3.64	0.61	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.76	15.41	1.68	1.44	2.17	0.96	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.14	10.47	3.12	0.45	2.23	0.45	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	5.67	11.34	0.33	1.00	0.33	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	13.01	5.57	1.86	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.98	10.55	1.13	1.13	0.75	0.38	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	15.26	26.17	0.00	1.74	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	5.62	5.62	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	41.92	9.89	5.65	1.41	2.83	0.24	0.47	0.24
adipose tissue, adult, pool1	10010-101C1	11.63	9.46	1.86	1.09	4.03	0.31	0.78	0.00
adipose, donor1	10184-103D4	25.80	4.69	2.35	0.00	0.59	1.17	0.00	0.59
adipose, donor2	10185-103D5	20.68	0.41	3.24	0.41	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	13.61	2.72	1.63	0.27	1.36	0.27	0.00	0.00
adipose, donor4	10187-103D7	29.47	5.20	3.47	0.00	0.87	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.25	8.52	0.47	1.89	0.79	0.00	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	7.28	14.55	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.75	34.95	1.33	5.87	1.47	0.27	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	24.65	4.64	5.00	1.79	1.43	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	13.22	13.91	0.93	2.32	1.62	0.70	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	20.96	12.51	2.03	2.03	0.68	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	10.90	15.02	0.59	1.18	1.18	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	4.74	2.37	1.19	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	3.45	8.72	0.20	0.20	0.81	0.20	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	1.29	1.29	0.32	0.65	0.32	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	16.17	6.62	1.02	0.51	1.27	0.64	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	7.50	18.31	0.44	2.43	0.44	0.44	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	3.67	9.02	0.33	1.00	1.34	0.67	0.00
aorta, adult, pool1	10052-101G7	17.06	6.86	1.18	0.98	1.57	0.20	0.39	0.20
appendix, adult	10189-103D9	7.37	31.83	1.55	1.94	1.55	0.78	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.97	23.73	1.03	2.75	1.03	0.69	0.34	0.00
artery, adult	10190-103E1	10.87	8.15	0.00	1.36	2.72	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	12.60	2.90	0.43	1.16	1.16	0.43	0.29	0.14
b cell line:RPMI1788	10427-106D4	8.77	22.90	0.59	1.78	0.00	0.45	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.16	7.49	0.55	1.39	0.28	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.65	8.63	0.60	1.89	1.29	0.40	0.60	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	15.23	3.51	0.33	0.33	1.51	0.50	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.67	13.42	7.83	1.68	2.80	1.68	0.56	0.00
bladder, adult, pool1	10011-101C2	19.01	9.56	1.20	0.98	1.63	0.11	0.22	0.11
blood, adult, pool1	10053-101G8	4.43	26.58	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	1.71	0.86	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	12.82	8.77	2.02	0.67	0.67	0.00	0.00	1.35
brain, adult, donor1	10084-102B3	9.23	2.05	0.00	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	6.35	4.23	0.89	0.11	0.56	0.22	0.33	0.11
brain, fetal, pool1	10085-102B4	8.01	0.00	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	76.64	16.52	9.91	4.63	3.63	3.96	0.99	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	125.20	21.84	15.10	6.62	7.61	8.24	1.25	0.25
breast, adult, donor1	10080-102A8	8.84	11.36	1.26	1.89	0.63	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	42.18	5.08	7.50	0.89	2.29	0.89	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.52	11.13	5.26	2.16	1.24	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.99	8.29	0.23	2.07	1.38	0.00	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	32.20	4.84	3.63	0.97	3.15	0.00	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	15.99	10.81	1.41	0.94	1.41	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	9.84	2.19	1.75	0.33	0.33	0.55	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	20.92	1.58	0.95	0.32	0.00	0.32	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	8.25	6.12	0.00	0.27	0.27	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	6.91	8.06	1.15	0.00	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	5.02	5.86	0.67	0.67	0.17	0.50	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	7.64	1.53	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	2.56	1.46	0.00	0.37	0.00	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	34.96	29.13	5.83	2.91	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	29.25	41.42	3.42	1.07	2.14	0.64	0.43	0.64
cerebellum, adult, pool1	10083-102B2	32.77	8.97	3.45	0.34	0.69	1.38	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	4.98	18.27	0.00	1.66	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	3.28	3.53	0.76	0.00	0.25	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	2.92	4.39	0.00	0.00	1.46	0.00	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	3.88	16.10	0.00	2.16	0.72	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	3.81	21.54	0.50	3.65	1.16	0.33	0.50	0.00
cervix, adult, pool1	10013-101C4	20.58	13.75	1.99	1.36	1.68	0.42	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	4.18	7.11	0.56	1.39	0.56	0.00	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	1.31	3.92	0.00	1.31	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.97	21.00	1.99	2.49	1.37	0.37	1.12	0.37
choriocarcinoma cell line:SCH	10785-110H2	19.84	13.80	0.86	2.71	2.71	0.86	0.49	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	21.35	12.33	0.71	1.66	1.42	0.47	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	12.25	18.80	1.14	2.56	0.85	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	11.93	7.36	1.89	2.09	0.80	0.30	0.00	0.10
chorionic membrane cells, donor3	12240-129G8	9.34	18.68	0.55	2.20	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	32.31	1.01	3.03	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	22.67	22.09	4.03	4.03	1.73	0.77	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.67	13.09	4.65	1.27	2.32	0.42	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.64	14.12	1.80	1.54	1.54	0.51	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	16.21	18.62	1.69	0.48	0.97	0.73	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.01	17.92	2.44	0.41	1.83	0.00	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	12.96	15.90	1.77	2.36	2.94	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	31.54	21.89	1.56	2.61	2.87	0.52	1.56	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.97	21.49	0.00	1.60	0.69	0.46	0.00	0.69
clear cell carcinoma cell line:TEN	10636-108I6	12.32	7.29	2.78	0.87	0.69	0.35	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	37.34	20.32	3.29	2.75	3.66	2.38	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	61.57	7.60	6.08	0.76	3.04	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	28.56	14.28	1.19	3.57	3.57	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	23.85	11.40	2.59	1.76	2.00	0.12	0.59	0.00
colon, fetal, donor1	10070-101I7	13.60	7.42	1.24	0.62	1.24	1.24	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	55.00	77.92	4.58	0.00	4.58	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.82	8.50	2.12	2.12	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	5.74	9.96	3.77	2.72	0.45	0.30	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	8.74	10.29	3.38	3.24	0.71	0.14	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	13.60	11.72	1.99	1.22	1.00	0.44	0.11	0.11
cruciate ligament, donor2	10295-104G7	8.10	7.29	4.05	0.81	1.62	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	6.42	11.24	3.21	0.80	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	3.84	3.60	0.72	0.00	0.24	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.19	28.01	4.59	2.98	1.15	0.69	0.46	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	0.51	19.49	0.00	3.59	0.00	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.61	2.65	4.57	0.24	2.17	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	29.90	15.95	3.99	3.49	3.49	1.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	11.52	0.00	0.00	4.32	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.03	16.18	1.47	0.00	0.00	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	26.92	4.05	2.15	0.83	3.30	0.33	0.99	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.87	4.00	10.44	0.89	0.67	2.89	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.55	4.87	8.60	1.43	1.43	1.29	0.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	3.08	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.37	2.72	1.21	0.61	1.51	0.00	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	10.19	2.78	1.23	0.93	0.62	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	15.76	2.63	0.00	1.31	2.63	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	23.80	6.70	2.35	0.00	2.35	2.35	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	15.41	7.07	1.09	1.27	0.54	0.00	0.72	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.63	10.94	2.41	2.41	0.64	0.32	0.16	0.80
epidermoid carcinoma cell line:A431	10426-106D3	27.01	8.00	3.78	2.00	1.67	0.67	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	10.23	26.18	1.10	3.85	1.10	0.33	0.33	0.22
epididymis, adult	10197-103E8	20.72	9.84	3.98	2.09	2.72	1.05	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	12.42	1.95	0.18	0.35	0.35	0.00	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	0.00	0.00	0.00	1.57	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2.23	15.33	0.00	5.24	0.52	0.13	0.13	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.98	11.22	0.10	3.35	0.10	0.10	0.20	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.78	19.38	0.22	4.82	0.78	0.11	0.56	0.34
esophagus, adult, pool1	10015-101C6	26.12	9.77	3.72	1.49	0.32	0.42	0.42	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	9.77	4.26	0.38	1.63	0.25	1.13	0.13	0.13
eye - muscle inferior rectus, donor1	10272-104E2	9.66	7.24	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	2.10	0.00	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	5.95	5.95	1.49	0.00	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	17.20	10.32	2.29	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	8.74	4.37	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	13.73	9.41	1.02	1.27	1.02	0.00	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	15.90	5.13	1.80	0.77	1.03	0.38	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.21	4.75	1.42	0.95	1.90	0.24	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	6.76	3.47	0.84	0.28	0.56	0.19	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	26.42	11.41	0.90	3.00	1.80	0.00	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.24	10.24	0.64	1.28	1.28	0.00	0.09	0.00
gall bladder, adult	10198-103E9	18.35	14.73	1.69	0.72	2.41	0.72	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	3.22	51.54	0.54	0.54	0.00	0.00	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	3.36	39.96	1.12	0.75	0.37	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.73	1.69	2.53	0.63	0.21	0.00	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.12	4.45	8.32	0.19	1.74	3.87	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	22.63	9.84	1.15	1.48	0.98	0.16	0.82	0.16
gastric cancer cell line:GSS	10560-108A2	37.52	16.47	7.32	2.75	2.75	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.94	12.57	0.23	2.06	1.14	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	3.90	2.98	0.57	0.69	0.23	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	20.99	7.70	0.70	1.82	0.70	0.14	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.45	3.24	5.74	0.75	1.00	0.50	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.78	4.12	1.48	1.06	0.74	0.42	0.63	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	18.54	4.21	2.81	1.12	0.70	0.28	1.26	0.00
glioblastoma cell line:T98G	10485-107A8	13.58	4.08	1.43	0.66	1.32	0.22	0.00	0.00
glioma cell line:GI-1	10413-106B8	17.87	11.13	1.76	0.59	0.59	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	8.02	5.83	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	10.50	15.62	1.22	0.49	0.24	0.73	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	2.74	8.22	1.37	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.26	2.13	0.00	0.53	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	58.73	17.13	4.89	9.79	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	32.79	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	6.40	2.56	1.28	0.32	0.00	0.00	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	30.76	10.56	2.75	0.00	0.92	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	22.86	6.86	1.37	0.46	0.91	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	35.43	7.73	3.86	0.00	0.64	0.00	0.64	0.64
hIPS, biol_rep1	14380-156B6	10.06	2.87	1.44	1.44	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	27.43	11.66	2.06	0.00	2.74	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	9.93	3.31	1.10	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	5.17	29.02	0.86	1.15	0.29	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	7.77	5.38	1.79	1.49	0.60	0.30	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	7.84	4.71	1.57	1.57	0.52	0.00	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	11.66	7.49	1.67	1.67	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	6.73	7.55	0.61	1.22	0.82	0.00	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	4.26	3.41	0.43	0.85	0.85	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	5.06	3.22	0.92	0.46	1.61	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	7.19	6.06	0.62	0.92	0.51	0.10	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	4.32	1.85	1.85	0.31	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	0.00	3.57	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	39.23	13.15	6.96	1.99	2.65	1.10	0.33	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	41.63	15.66	6.43	1.70	2.67	0.61	0.61	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	40.62	17.48	6.27	3.13	2.22	1.11	0.81	1.11
hepatoma cell line:Li-7	10484-107A7	21.69	5.78	1.89	1.33	1.22	0.56	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	23.32	18.79	2.91	2.01	3.02	0.60	0.50	0.20
hippocampus - adult, donor10196	10169-103B7	1.89	2.84	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	5.71	11.43	0.20	1.22	0.41	0.00	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	3.49	4.48	0.00	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	3.88	3.17	0.00	0.70	0.35	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.26	12.82	4.27	1.22	1.83	0.00	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.97	11.19	2.75	1.18	1.96	0.20	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	23.61	10.92	2.54	1.52	2.79	0.00	0.76	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.07	4.51	6.20	0.00	1.13	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	25.30	3.61	7.49	0.00	0.26	0.00	0.00	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.99	6.07	4.18	1.14	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	13.14	2.63	2.04	0.00	0.00	0.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	20.47	2.37	4.09	0.43	0.86	0.00	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	12.51	2.92	1.67	0.42	0.42	0.00	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.71	2.84	1.89	0.00	0.24	0.24	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.02	2.57	2.89	0.16	0.16	0.16	0.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	11.45	0.00	0.67	0.67	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	24.72	10.80	3.91	0.94	2.19	0.31	0.47	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	25.55	7.37	0.98	0.98	2.95	0.49	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	7.85	0.87	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.20	1.91	7.25	0.38	0.57	0.19	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	28.78	5.67	6.98	0.44	1.74	1.31	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.99	6.50	5.00	0.50	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.51	0.57	2.07	0.00	0.38	0.19	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.37	1.36	2.27	0.00	0.00	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	13.78	0.63	2.82	0.00	0.31	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.92	2.45	3.76	0.33	0.49	0.00	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.93	1.45	3.19	0.00	0.29	1.16	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.85	0.90	1.49	0.00	1.20	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.06	7.02	3.88	1.11	1.85	0.74	0.18	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.39	7.42	2.00	1.43	3.14	0.29	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	27.36	7.35	3.27	1.22	0.82	1.63	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.24	4.22	4.93	0.00	0.70	0.35	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.41	3.17	6.65	1.27	0.00	0.63	0.00	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.60	3.63	6.05	0.30	1.21	0.61	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	3.10	3.10	0.00	0.52	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	18.60	2.66	4.65	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	10.52	3.59	4.10	0.00	0.00	0.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	11.76	4.60	1.79	0.00	0.51	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.20	4.54	1.51	0.76	0.76	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	2.35	2.02	0.00	1.01	0.34	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.74	7.73	4.11	0.48	1.93	0.24	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	15.15	8.47	2.67	0.45	0.89	1.78	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.88	8.78	6.34	0.49	1.46	0.49	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	26.28	2.44	6.11	0.00	0.31	0.61	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	3.25	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	19.19	4.30	4.63	0.33	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.87	1.64	1.64	0.00	0.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	2.90	2.17	0.36	0.00	0.00	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.54	1.42	1.42	0.00	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	0.00	0.00	1.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	10.02	2.03	1.22	0.68	0.27	0.41	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.85	2.96	0.54	0.00	0.27	0.27	0.00	0.00
immature langerhans cells, donor1	11904-125F5	13.32	5.33	0.97	0.24	1.21	0.24	1.21	0.24
immature langerhans cells, donor2	11905-125F6	19.01	7.13	3.17	0.00	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	8.33	5.11	0.76	0.19	0.28	0.19	0.57	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	46.50	4.23	8.45	0.65	1.63	1.95	0.65	0.00
kidney, adult, pool1	10017-101C8	11.61	6.91	0.90	2.50	1.90	0.30	0.40	0.10
kidney, fetal, pool1	10045-101F9	12.80	10.68	0.71	1.41	1.20	0.28	0.50	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	13.21	5.54	0.43	0.71	1.42	0.14	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.56	1.24	1.52	0.41	1.52	0.14	0.28	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	0.55	9.91	0.00	1.10	0.18	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	7.08	2.18	0.54	1.09	1.63	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	4.05	1.01	0.51	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	12.59	2.46	1.37	0.27	0.55	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	4.67	5.39	1.44	0.36	0.36	0.72	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	4.35	4.89	0.54	0.00	1.09	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	7.04	5.10	0.49	0.49	0.73	0.24	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	4.18	1.05	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	42.62	14.05	7.44	1.42	2.01	0.59	0.59	0.24
liposarcoma cell line:KMLS-1	10782-110G8	12.34	5.47	1.72	0.47	0.94	0.62	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	24.00	3.66	3.41	0.97	1.34	0.61	0.37	0.12
liver, adult, pool1	10018-101C9	12.15	5.67	1.30	1.78	1.46	0.49	0.32	0.00
liver, fetal, pool1	10086-102B5	2.82	3.76	0.94	0.00	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	4.67	4.52	0.73	0.00	0.44	0.73	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	5.54	12.18	0.18	0.37	0.92	0.37	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	5.08	3.10	0.85	0.85	0.85	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	3.79	2.10	0.00	0.42	1.26	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	6.37	2.21	0.55	0.28	0.55	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	6.89	3.45	3.45	1.38	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	19.64	7.38	1.98	0.92	0.79	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	14.77	9.69	1.30	1.42	0.59	0.12	0.35	0.00
lung, fetal, donor1	10068-101I5	17.41	23.97	0.29	2.00	1.14	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	16.95	14.66	2.75	0.92	0.46	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	11.83	15.15	2.84	0.95	0.95	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	8.55	19.07	0.66	1.75	0.22	0.00	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.56	33.81	3.32	4.23	0.30	2.11	0.15	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	6.80	5.95	1.70	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	20.87	3.55	1.33	1.33	4.88	0.44	0.89	0.00
mature adipocyte, donor2	12232-129F9	17.02	4.77	0.62	1.87	2.28	0.21	0.83	0.00
mature adipocyte, donor3	12233-129G1	23.94	4.27	1.66	0.24	3.56	0.00	0.47	0.24
mature adipocyte, donor4	12234-129G2	28.16	3.16	2.11	2.11	2.90	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.59	7.15	2.62	1.43	1.43	0.24	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	5.64	1.13	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	5.33	9.01	1.10	0.92	0.74	0.37	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	3.81	4.13	0.32	0.00	0.00	1.27	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	0.85	2.13	0.00	0.43	0.43	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	4.89	6.08	0.84	0.17	0.34	0.34	0.17	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	6.79	8.70	0.42	0.21	0.21	0.21	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	1.93	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2.15	6.10	0.00	0.00	0.36	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	8.44	8.44	0.65	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	6.81	13.62	0.46	0.31	0.62	0.31	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	11.51	8.08	1.06	0.49	0.98	0.16	0.08	0.00
medulla oblongata, newborn, donor10223	10361-105F1	1.74	6.94	0.00	0.35	1.04	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	57.12	10.41	7.53	0.44	1.77	1.55	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	15.90	7.46	3.06	0.98	1.47	0.12	0.37	0.24
melanoma cell line:COLO 679	10514-107E1	7.04	18.69	1.58	1.15	0.57	0.00	0.14	0.14
melanoma cell line:G-361	10465-106H6	28.78	3.80	5.16	1.63	1.63	0.27	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	15.56	4.16	1.27	1.27	1.27	0.54	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	64.32	21.15	14.98	2.64	0.00	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	46.40	49.25	8.30	2.85	1.56	2.33	0.26	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	16.11	4.76	4.45	0.77	1.23	1.53	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.72	3.82	1.82	0.55	0.73	0.36	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	3.73	0.41	2.07	0.41	0.41	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.35	6.18	0.42	0.42	0.42	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	4.24	1.73	0.19	0.96	1.35	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	5.55	4.86	0.69	0.69	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.98	5.84	0.86	1.89	0.34	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.82	6.21	0.92	1.15	0.92	0.12	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.48	5.70	2.39	0.53	0.53	0.27	0.93	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.21	7.56	0.81	0.81	0.41	0.14	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.41	5.26	0.14	0.71	0.28	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	2.31	4.94	0.66	1.32	0.33	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.27	7.33	2.08	0.42	0.83	0.28	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.93	8.03	0.35	0.70	0.35	0.00	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	3.67	6.94	0.41	1.22	0.41	0.00	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	4.31	3.59	0.72	1.08	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.76	5.28	0.31	0.52	0.21	0.00	0.21	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.56	5.70	0.68	0.68	0.23	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	6.71	12.17	0.84	0.84	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.77	5.08	0.45	0.60	0.30	0.30	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	5.51	6.48	0.96	1.14	0.53	0.35	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2.95	6.26	0.37	0.74	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	4.01	5.72	0.29	0.00	0.29	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.42	10.10	0.42	1.26	0.42	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.70	4.11	2.28	0.91	0.91	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.21	4.35	2.05	0.26	0.51	0.51	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.95	4.71	1.31	1.05	1.05	1.05	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.40	4.31	2.46	0.92	0.62	0.62	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.06	3.77	1.41	0.47	0.94	1.18	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.85	5.42	1.35	0.34	1.02	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.40	2.36	0.39	1.18	0.79	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.12	5.56	0.46	0.93	1.39	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.57	6.63	2.60	0.58	1.44	0.58	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.29	2.68	2.01	0.67	0.89	0.45	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.42	2.64	1.44	1.20	0.96	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	3.67	1.47	0.73	3.67	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.76	3.02	1.68	1.01	1.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	9.42	3.68	1.64	0.41	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	8.59	3.44	3.01	0.86	1.29	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	8.20	5.47	2.73	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	2.92	0.97	0.97	0.97	0.32	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	1.45	2.91	1.45	1.45	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	3.20	2.67	0.53	1.07	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	5.72	0.00	1.64	1.64	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	3.50	2.33	1.17	0.78	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30	0.00	0.00	2.10	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	6.95	0.00	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	3.56	1.19	0.59	1.19	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	3.66	0.00	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.90	3.80	4.43	1.27	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	32.77	5.86	8.28	2.76	2.07	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	0.00	17.19	4.30	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	3.44	0.00	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.86	6.52	8.56	1.63	1.63	1.63	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	8.74	7.15	3.18	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.24	12.38	6.48	2.95	2.95	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.43	11.84	9.04	1.25	4.68	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	10.69	6.68	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	17.74	10.64	1.18	0.00	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	12.84	5.14	7.70	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	15.14	8.26	4.82	1.38	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	18.80	4.45	2.47	0.49	0.99	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	10.09	1.12	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.90	3.18	3.18	1.27	1.27	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	2.82	1.21	0.81	2.42	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	10.90	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	5.07	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	3.64	0.00	0.61	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	5.77	0.82	0.00	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.08	7.54	3.97	0.79	1.79	0.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.90	8.76	3.89	0.97	2.60	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	13.24	3.06	2.04	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	1.55	1.55	0.00	0.77	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	12.76	5.67	0.71	0.24	1.42	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.50	4.17	1.62	0.23	1.62	0.46	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2.98	4.42	0.21	0.72	0.92	0.10	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	4.31	2.95	0.68	0.68	1.36	0.45	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	17.11	5.38	1.71	0.98	1.96	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	9.30	10.19	0.89	2.44	1.11	0.66	0.89	0.44
mesothelioma cell line:Mero-82	10853-111F7	12.09	2.10	2.10	0.53	0.26	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	31.15	7.49	2.72	0.68	2.38	1.36	0.68	0.51
mesothelioma cell line:Mero-84	10855-111F9	16.68	5.56	2.02	1.26	2.27	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	9.52	5.59	0.83	0.21	0.21	0.62	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	8.94	7.62	1.16	1.16	0.33	0.33	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	13.76	3.62	1.63	0.90	1.81	0.36	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	13.32	4.95	1.20	1.71	1.02	0.34	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	9.42	12.21	0.00	1.53	2.04	0.00	0.51	0.00
mesothelioma cell line:No36	10857-111G2	13.37	7.18	0.00	1.63	2.28	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	12.73	5.96	1.35	1.63	1.90	0.54	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	3.45	10.94	0.00	2.30	0.19	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	3.30	21.98	0.24	3.30	0.24	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	4.85	17.05	0.18	2.33	0.36	0.18	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	7.51	5.22	1.31	0.33	0.33	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.21	6.36	0.21	1.48	0.64	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.50	2.30	2.30	0.23	0.23	0.46	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.62	17.51	1.33	2.09	0.19	0.57	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	48.60	21.44	3.14	2.22	6.10	1.11	1.48	0.74
myeloma cell line:PCM6	10474-106I6	21.15	34.00	0.99	2.97	1.78	0.20	1.19	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.61	2.03	2.03	0.51	1.01	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.12	9.81	0.59	2.35	0.98	0.00	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.80	3.12	0.78	0.22	0.78	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.99	2.13	1.03	0.22	0.51	0.15	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	15.46	3.31	1.66	0.00	1.66	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	63.96	5.52	7.36	0.46	1.15	0.92	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	44.15	16.09	7.86	1.31	1.50	1.12	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	36.48	1.90	8.65	0.21	0.63	1.27	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	68.95	11.74	11.55	0.37	1.49	1.12	0.00	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.86	2.37	2.61	0.00	0.24	0.00	0.00	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.60	2.06	3.96	0.48	0.95	0.16	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	22.54	5.03	2.42	0.00	0.81	0.20	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	0.64	3.81	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	7.72	2.93	2.40	1.06	0.53	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	44.62	104.12	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	79.68	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	37.88	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	37.21	41.94	4.40	7.10	2.20	0.51	0.85	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	10.41	0.00	1.60	0.80	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.09	3.53	0.96	0.96	1.60	0.00	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.99	2.10	1.31	0.79	1.05	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	7.22	4.69	1.41	0.47	0.47	0.09	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	2.06	8.24	0.00	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	5.10	16.37	0.54	0.54	1.34	0.81	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	4.00	3.64	0.00	0.36	0.73	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	5.25	3.15	3.67	0.00	0.52	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	6.44	0.86	0.00	0.00	0.00	0.00	0.43	0.00
occipital pole, adult, pool1	10036-101E9	7.17	4.57	0.55	0.32	0.55	0.16	0.08	0.08
olfactory region, adult	10195-103E6	5.35	6.30	0.38	0.00	0.76	0.76	0.00	0.00
optic nerve, donor1	10277-104E7	14.01	10.01	10.01	0.00	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.32	7.75	2.28	1.48	1.82	1.37	0.46	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	61.82	13.60	3.85	0.82	2.34	0.27	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.24	2.88	2.88	0.17	1.35	0.51	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.76	2.31	3.93	0.23	0.69	0.81	0.23	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	5.88	3.23	0.88	0.29	0.59	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.03	7.47	1.87	0.93	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.72	4.45	4.88	0.64	1.27	1.06	0.21	0.00
ovary, adult, pool1	10020-101D2	10.74	10.39	1.14	1.48	0.87	0.17	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.72	4.95	2.02	0.55	0.92	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	31.04	11.29	8.47	0.00	4.70	1.88	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	9.22	16.21	1.96	3.07	0.84	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	12.61	8.69	0.51	1.87	1.02	0.34	0.51	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.86	14.90	1.32	1.82	1.16	0.50	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	6.50	4.12	0.82	0.18	0.55	0.46	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	3.67	0.73	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	2.82	0.00	0.00	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	6.27	9.12	0.29	0.29	0.57	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	7.14	5.90	0.44	0.26	0.62	0.44	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	9.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	1.50	2.24	0.00	0.37	0.00	0.75	0.00	0.00
parotid gland, adult	10199-103F1	40.08	22.20	8.02	4.93	3.08	1.85	0.62	1.85
penis, adult	10200-103F2	18.26	9.13	2.15	4.30	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.27	2.97	0.56	0.00	0.74	0.19	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.30	2.91	1.89	1.02	1.02	0.73	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	5.16	4.52	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	7.70	8.88	0.59	0.00	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	1.88	4.39	1.25	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	12.14	17.20	2.02	1.01	0.00	1.01	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	13.55	28.14	1.04	0.52	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	11.92	25.54	3.40	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	17.20	21.39	1.51	3.23	2.37	0.75	0.65	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	9.01	23.70	1.06	1.32	0.66	0.26	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	6.07	8.40	1.09	1.09	0.93	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	7.23	5.08	0.43	0.09	0.69	0.00	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	6.10	5.23	1.22	0.52	0.52	0.35	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	58.56	4.18	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	35.21	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	37.58	8.59	2.18	1.89	2.77	0.15	0.73	0.15
prostate cancer cell line:PC-3	10439-106E7	43.38	9.62	6.17	2.54	1.82	1.09	0.54	0.18
prostate, adult, pool1	10022-101D4	19.14	12.06	2.00	1.45	1.36	1.00	0.36	0.27
putamen, adult, donor10196	10176-103C5	3.78	5.90	1.42	0.24	0.24	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	7.84	5.88	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	1.09	0.00	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.14	4.35	0.48	0.24	0.48	0.48	0.48	0.00
putamen, newborn, donor10223	10365-105F5	0.00	0.75	0.00	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	19.78	5.24	3.49	0.58	0.87	2.62	0.29	0.29
rectum, fetal, donor1	10067-101I4	15.30	6.95	1.39	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.11	6.57	1.06	1.91	0.21	0.00	0.42	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	6.21	2.90	0.41	0.83	0.83	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	15.80	8.45	1.29	0.50	1.49	0.99	0.30	0.10
retinoblastoma cell line:Y79	10475-106I7	54.04	5.46	12.99	0.78	0.52	0.78	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	20.04	3.20	0.61	0.37	1.23	0.25	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	30.09	3.09	6.75	0.56	0.84	0.28	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	3.03	4.55	0.76	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	26.06	3.88	3.72	0.32	2.27	0.65	0.65	1.13
salivary acinar cells, donor2	11772-123I8	47.64	6.06	7.02	1.65	3.86	3.17	0.96	1.10
salivary acinar cells, donor3	11773-123I9	43.03	6.62	4.63	0.66	3.31	4.63	0.66	0.00
salivary gland, adult, pool1	10093-102C3	41.75	13.15	1.72	1.72	2.29	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.25	3.29	0.67	1.18	2.61	0.59	1.10	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	16.93	5.29	0.47	1.29	1.65	0.47	0.35	0.24
seminal vesicle, adult	10201-103F3	29.63	8.99	3.70	2.12	1.59	1.59	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.10	17.00	0.73	1.70	1.46	0.24	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.56	9.81	1.01	1.26	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	8.03	0.00	4.01	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.40	11.82	3.76	1.07	1.34	0.94	0.13	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	30.28	8.73	1.44	1.44	1.88	0.77	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	53.29	16.52	12.64	3.10	3.23	1.42	0.65	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	9.93	2.13	2.84	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	6.48	3.00	0.60	0.36	0.72	0.12	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	7.04	6.03	1.01	0.00	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	13.57	6.79	6.79	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.04	10.10	3.79	1.26	0.63	1.26	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.00	20.01	0.00	2.33	0.00	0.00	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.29	19.86	2.84	0.63	1.26	1.26	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.79	6.17	0.58	0.39	1.54	0.00	0.58	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	46.81	2.47	9.07	0.16	0.66	0.82	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.15	8.53	5.95	0.16	0.32	0.00	0.00	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	30.29	4.14	1.96	0.00	0.87	1.09	0.00	0.00
small intestine, adult, pool1	10024-101D6	25.56	13.97	1.43	3.94	2.63	0.00	0.84	0.12
small intestine, fetal, donor1	10064-101I1	12.78	11.30	1.97	0.98	0.49	2.21	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.54	4.62	2.05	2.56	1.03	0.51	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	16.28	7.50	1.55	0.78	1.55	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	21.98	3.75	2.68	0.27	0.27	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	6.65	4.82	0.92	0.23	0.69	0.23	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	5.13	12.22	0.39	0.39	0.79	0.00	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	5.53	4.15	0.00	0.00	2.08	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	9.15	9.76	0.61	0.61	1.22	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	3.67	7.35	0.46	0.46	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	5.53	1.34	1.19	0.60	0.00	0.00	0.30	0.00
spleen, adult, pool1	10025-101D7	9.91	19.82	1.21	1.76	1.87	0.33	0.33	0.11
spleen, fetal, pool1	10044-101F8	13.67	26.94	1.75	2.70	1.27	0.16	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.38	19.98	1.24	3.00	1.35	0.31	0.41	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	19.18	3.61	1.14	0.57	0.76	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	6.64	9.09	0.35	1.75	1.05	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.59	3.91	0.78	0.39	0.39	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.79	9.45	1.69	1.46	0.68	0.34	0.45	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	34.74	23.72	7.62	2.54	2.97	0.42	0.85	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	2.12	9.31	0.00	3.38	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	34.18	8.54	8.54	0.00	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	23.36	20.51	7.98	4.56	3.42	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	8.93	16.62	1.04	1.66	1.45	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	7.76	0.52	0.52	0.52	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	2.83	2.83	0.00	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	42.87	5.50	5.50	1.38	1.83	1.38	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	10.26	5.68	0.51	0.68	0.93	0.34	0.42	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.14	2.14	0.00	0.00	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	5.71	2.64	0.00	0.44	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	14.66	5.59	2.44	1.40	1.40	0.35	0.00	0.70
tenocyte, donor2	11765-123I1	14.12	7.63	1.14	0.76	0.76	0.00	0.38	0.76
tenocyte, donor3	11768-123I4	11.49	4.82	1.85	2.22	1.85	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	21.25	12.41	2.04	1.02	1.36	0.85	0.51	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	23.28	14.64	2.62	1.23	1.08	0.31	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	23.56	5.42	3.41	0.15	1.08	0.46	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.31	11.55	1.27	1.65	1.78	0.25	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.15	10.21	4.92	0.00	1.51	0.38	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.47	5.56	1.20	0.44	0.44	0.11	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.66	12.05	1.95	1.95	0.98	0.65	0.00	1.95
testis, adult, pool1	10026-101D8	21.26	9.66	3.22	1.18	1.61	0.32	0.64	0.00
testis, adult, pool2	10096-102C6	22.55	12.18	5.41	0.90	2.71	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	13.25	9.94	0.00	2.21	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	8.28	14.38	2.19	0.63	1.25	0.16	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.96	3.95	0.99	0.33	0.99	0.16	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	1.73	0.58	0.00	0.00	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	18.48	12.98	1.50	1.75	1.75	0.00	0.25	0.00
throat, fetal, donor1	10061-101H7	12.49	9.14	1.52	0.91	0.00	0.61	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	37.36	4.77	5.17	0.79	2.19	2.78	0.40	0.40
thymus, adult, pool1	10027-101D9	9.15	52.29	1.39	2.88	0.80	0.30	0.00	0.20
thymus, fetal, pool1	10043-101F7	8.21	49.87	0.62	3.43	0.62	0.00	0.21	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.65	6.25	1.06	0.93	1.60	0.27	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	12.01	6.29	0.70	0.70	0.70	0.00	0.14	0.14
thyroid, adult, pool1	10028-101E1	20.25	13.44	1.49	2.24	2.15	0.19	0.19	0.28
thyroid, fetal, donor1	10060-101H6	10.02	8.17	0.26	1.05	1.05	0.00	0.00	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	3.08	0.00	9.24	0.00	0.00	0.00
tongue, adult	10203-103F5	20.23	7.21	0.93	1.86	0.93	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	13.01	5.52	1.97	0.39	0.79	0.00	0.79	0.00
tonsil, adult, pool1	10047-101G2	18.23	27.85	1.70	2.20	1.00	0.40	0.30	0.00
trachea, adult, pool1	10029-101E2	20.29	9.73	2.45	1.64	1.64	0.41	0.57	0.16
trachea, fetal, donor1	10058-101H4	20.39	12.31	6.16	1.15	0.77	0.00	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.15	3.90	3.19	1.06	0.71	0.35	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	36.27	10.44	3.24	1.42	1.22	0.10	0.41	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.80	11.44	0.31	1.10	0.94	0.00	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	5.71	1.90	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.28	5.33	1.95	1.19	0.93	0.25	0.51	0.08
umbilical cord, fetal, donor1	10057-101H3	6.26	10.43	0.00	2.09	4.17	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	15.70	12.11	0.34	0.85	1.71	0.85	0.51	0.17
uterus, fetal, donor1	10055-101H1	16.89	8.19	1.54	1.54	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	9.05	12.92	0.00	3.23	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	10.30	27.18	1.53	3.51	2.19	0.88	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.87	21.90	0.00	0.27	0.27	0.27	0.00	0.00